10
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Fibromyalgia

Pages 21-161 | Published online: 04 Dec 2011

References

  • Aarflot T; Bruusgaard D. Association between chronic widespread musculoskeletal complaints and thyroid autoimmunity. Results from a community survey. Scandi-navian Journal of Primary Health Care 14(2):111–115, 1996.
  • Aaron LA; Bradley LA; Alarcon GS; Alexander RW; Triana-Alexander M; Martin MY; Alberts KR. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis and Rheumatism 39(3):436–445, 1996.
  • Aaron LA; Bradley LA; Alarcon GS; Triana-Alexander M; Alexander RW; Martin MY; Alberts KR. Perceived physical and emotional trauma as precipitating events in fibromyalgia. Associations with health care seeking and disability status but not pain severity. Arthritis and Rheumatism 40(3):453–460, 1997.
  • Aaron LA; Buchwald D. Tobacco use and chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Archives of Internal Medicine 160(15):2398–2401, 2000.
  • Aaron LA; Burke MM; Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Ar-chives of Internal Medicine 160(2):221–227, 2000.
  • Abu-Shakra M; Mader R; Langevitz P; Friger M; Codish S; Neumann L; Buskila D. Quality of life in systemic lupus erythematosus: a controlled study. Journal of Rheumatology 26(2):306–309, 1999.
  • Acasuso-Diaz M; Collantes-Estevez E. Joint hypermobility in patients with fibro-myalgia syndrome. Arthritis Care Research 11(1):39–42, 1998.
  • Ackenheil M. Genetics and pathophysiology of affective disorders: relationship to fibromyalgia. Zeitschrift Rheumatologie 57 Suppl 2:5–7, 1998.
  • Acupuncture. NIH Consensus Statement 15(5):1–34, 1997.
  • Adler GK; Kinsley BT; Hurwitz S; Mossey CJ; Goldenberg DL. Reduced hypotha-lamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. American Journal of Medicine 106(5):534–543, 1999.
  • Affleck G; Urrows S; Tennen H; Higgins P; Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 68(2-3):363–368, 1996.
  • Affleck G; Tennen H; Urrows S; Higgins P; Abeles M; Hall C; Karoly P; Newton C. Fibromyalgia and women's pursuit of personal goals: a daily process analysis. Health Psychology 17(1):40–47, 1998.
  • Agargun MY; Tekeoglu I; Gunes A; Adak B; Kara H; Ercan M. Sleep quality and pain threshold in patients with fibromyalgia. Comprehensive Psychiatry 40(3):226–228, 1999.
  • Akama H. Management of fibromyalgia. Annals of Internal Medicine 132(12):1005, 2000.
  • Akkasilpa S; Minor M; Goldman D; Magder LS; Petri M. Association of coping re-sponses with fibromyalgia tender points in patients with systemic lupus ery-thematosus. Journal of Rheumatology 27(3):671–674, 2000.
  • Akkus S; Delibas N; Tamer MN. Do sex hormones play a role in fibromyalgia? Rheumatology (Oxford) 39(10):1161–1163, 2000.
  • Alagiri M; Chottiner S; Ratner V; Slade D; Hanno PM. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 49(5A Suppl): 52–57, 1997.
  • Alarcon GS. Arthralgias, myalgias, facial erythema, and a positive ANA: not necessar-ily SLE. Cleveland Clinic Journal of Medicine 64(7):361–364, 1997.
  • Alarcon GS; Bradley LA. Advances in the treatment of fibromyalgia: current status and future directions. American Journal of Medical Sciences 315(6):397–404, 1998.
  • Alexander RW; Bradley LA; Alarcon GS; Triana-Alexander M; Aaron LA; Alberts KR; Martin MY; Stewart KE. Sexual and physical abuse in women with fibro-myalgia: association with outpatient health care utilization and pain medication us-age. Arthritis Care Res 11(2):102–115, 1998.
  • Allerheiligen DA; Schoeber J; Houston RE; Mohl VK; Wildman KIVI. Hyperpar-athyroidism. American Family Physician 57(8):1795–1802, 1807–1808, 1998. Alloway JA; Older SA; Battafarano DF; Carpenter MT. Persian Gulf War myalgiasyndrome. Journal of Rheumatology 25(2):388–389, 1998.
  • Alvarez Lario B; Alonso Valdivielso IL; Alegre Lopez J; Martel Soteres C; Viejo Banuelos IL; Maranon Cabello A. Fibromyalgia syndrome: overnight falls in arte-rial oxygen saturation. American Journal of Medicine 101(1):54–60, 1996.
  • Alvarez Lario B; Viejo Banuelos JL. [Sleep respiratory disorders in fibromyalgia syn-drome] Trastornos respiratorios del sueno en el sindrome de fibromialgia. Archives of Bronconeumology 33(3):143–147, 1997.
  • Alvarez Lario B; Alonso Valdivielso IL; Alegre Lopez J. [Pathophysiology of pain in fibromyalgia syndrome: on the threshold of its understanding] Fisiopatologia del dolor en el sindrome de fibromialgia: en el umbral de su comprension. Medicina Clinica (Barc) 112(16):621–630, 1999.
  • Ambrogio N; Cuttiford J; Lineker S; Li L. A comparison of three types of neck support in fibromyalgia patients. Arthritis Care Research 11(5):405–410, 1998.
  • Amir M; Kaplan Z; Neumann L; Sharabani R; Shani N; Buskila D. Posttraumatic stress disorder, tenderness and fibromyalgia. Journal of Psychosomatic Research 42(6): 607–613, 1997.
  • Ammer K; Melnizky P. [Medicinal baths for treatment of generalized fibromyalgia] Medizinalbader zur therapie der generalisierten fibromyalgie. Forschrtft Komple-mentarmedizin 6(2):80–85, 1999.
  • Anch AM; Lue FA; MacLean AW; Moldofsky H. Sleep physiology and psychological aspects of fibrositis (fibromyalgia) syndrome. Canadian Journal of Experimental Psychology 45:179–184, 1991.
  • Anderberg UM; Liu Z; Berglund L; Nyberg F. Plasma levels of nociceptin in female fibromyalgia syndrome patients. Zeitschrtft Rheumatolo gie 57 Suppl 2:77–80, 1998.
  • Anderberg UM; Liu Z; Berglund L; Nyberg F. Elevated plasma levels of neuropeptide Y in female fibromyalgia patients. European Journal of Pain 3(1):19–30, 1999.
  • Anderberg UM. [Stress can induce neuroendocrine disorders and pain] Stress kan ge neuroendokrina storningar och smartfillstand. Lakartidningen 96(49):5497–5499, 1999.
  • Anderberg UM. [Fibromyalgia-probably a result of prolonged stress syndrome] Fibro-myalgi-sannolikt ett resultat av langvarigt stressyndrom. Lakartidningen 97(21): 2641–2642, 2000.
  • Anderberg UM; Marteinsdottir I; Theorell T; von Knorring L. The impact of life events in female patients with fibromyalgia and in female healthy controls. European Psy-chiatry 15(5):295–301, 2000.
  • Anderberg UM. Comment on: Johns and Littlejohn, The role of sex hormones in pain response. Pain 87(1):109–111, 2000.
  • Anderberg UM; Marteinsdottir I; von Knorring L. Citalopram in patients with fibro-myalgia-a randomized, double-blind, placebo-controlled study. European Journal of Pain 4(1):27–35, 2000.
  • Andersson M; Bagby JR; Dyrehag L; Gottfries C. Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome. European Journal of Pain 2(2):133–142, 1998.
  • Ang D; Wilke WS. Diagnosis, etiology, and therapy of fibromyalgia. Comprehensive Therapy 25(4):221–227, 1999.
  • Angell M. Antipolymer antibodies, silicone breast implants, and fibromyalgia. Lancet 349(9059):1171–1172; discussion 1172–1173, 1997.
  • Anisman H; Baines MG; Berczi I; Bernstein CN; Blennerhassett MG; Gorczynski RM; Greenberg AH; Kisil FT; Mathison RD; Nagy E; Nance DM; Perdue MH; Pomerantz DK; Sabbadini ER; Stanisz A; Warrington RJ. Neuroimmune mechanisms in health and disease: 2. Disease. Canadian Medical Association Journal 155(8):1075–1082, 1996.
  • Argov Z; Lofberg M; Arnold DL. Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle Nerve 23(9):1316–1334, 2000.
  • Armstrong R. Fibromyalgia: is recovery impeded by the internet? Archives of Internal Medicine 160(7):1039–1040, 2000.
  • Amer S; Gustafsson L; Hansson P; Kinnman E; Sollevi A; Sorensen J. [Pharmacologi-cal pain analysis as diagnostic and therapeutic help] Farmakologisk smartanalys hjalp vid diagnostik och terapival. Lakartidningen 95(24):2824–2828, 1998.
  • Arnold LM; Keck PE Jr; Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41(2):104–113, 2000.
  • Aronoff GM. Myofascial pain syndrome and fibromyalgia: a critical assessment and alternate view. Clinical Journal of Pain 14(1):74–85, 1998.
  • Asencio-Marchante JJ; Terriza-Garcia F. [Myalgia-fasciculation syndrome] Sindrome de mialgia-fasciculacion. Revista Neurologica 26(149):162, 1998.
  • Atkins CJ; Zielinski A; Makosinski A. Palpometry: a novel concept in pain measure-ment. Nature Medicine 1(11):1138–1139, 1995.
  • Atkinson JH; Ancoli-Israel S; Slater MA: Garfin SR; Gillin JC. Subjective sleep dis-turbances in chronic back pain. Clinical Journal of Pain 4:225–232, 1988.
  • Auvenshine RC. Psychoneuroimmunology and its relationship to the differential diag-nosis of temporomandibular disorders. Dentistry Clinics of North America 41(2): 279–296, 1997.
  • Avina-Zubieta JA; Paez F; Galindo-Rodriguez G. Rheumatic manifestations of neuro-logic and psychiatric diseases. Current Opinions in Rheumatology 9(1):51–55, 1997.
  • Avon SL. [Fibromyalgia in dentistry]] La fibromyalgie en medecine dentaire. Journal of the Canadian Dental Association 62(11):874–876, 879–880, 1996.
  • Azpiroz F; Dapoigny M; Pace F; Muller-Lissner S; Coremans G; Whorwell P; Stockbrugger RW; Smout A: Nongastrointestinal disorders in the irritable bowel syndrome. Digestion 62(1):66–72, 2000.
  • Bagge E; Bengtsson BA; Carlsson L; Carlsson J. Low growth hormone secretion in pa-tients with fibromyalgia-a preliminary report on 10 patients and 10 controls. Jour-nal of Rheumatology 25(1):145–148, 1998.
  • Bailey DR. Sleep disorders. Overview and relationship to orofacial pain. Dentistry Clinics of North America 41(2):189–209, 1997.
  • Bakker C; van der Linden S; van Santen-Hoeufft M; Bolwijn P; Hidding A. Problem elicitation to assess patient priorities in ankylosing spondylitis and fibromyalgia. Journal of Rheumatology 22(7):1304–1310, 1995.
  • Bakker C; Rutten M; van Santen-Hoeufft M; Bolwijn P; van Doorslaer E; Bennett K; van der Linden S. Patient utilities in fibromyalgia and the association with other outcome measures. Journal of Rheumatology 22(8):1536–1543, 1995.
  • Baraczka K; Janko Z; Vargha K; Markus H. [Clinical experiences with the analgesic effects of citalopram] Klinikai tapasztalatok a citalopram fajdalomcsillapito hatasarol. Orv Hetil 138(41):2605–2607, 1997.
  • Baraniuk JN; Clauw D; Yuta A; Ali M; Gaumond E; Upadhyayula N; Fujita K; Shimizu T. Nasal secretion analysis in allergic rhinitis, cystic fibrosis, and non-allergic fibromyalgia/chronic fatigue syndrome subjects. American Journal of Rhinology 12(6):435–440, 1998.
  • Baraniuk JN; Naranch K; Maibach H; Clauw D. Irritant rhinitis ins allergic, non-allergic, control and chronic fatigue syndrome populations. Journal of Chronic Fa-tigue Syndrome 7(2):3–32, 2000.
  • Barker E; Fujimura SF; Fadem MB; Landay AL; Levy JA. Immunologic abnormalities associated with chronic fatigue syndrome. Clinical Infectious Diseases 18\(supp 1):5136-S141, 1994.
  • Barkhuizen A; Bennett RM. Hepatitis C infection presenting with rheumatic manifes-tations. Journal of Rheumatology 24(6):1238–1239, 1997.
  • Barkhuizen A; Bennett RM. Elevated levels of hyaluronic acid in the sera of women with fibromyalgia. Journal of Rheumatology 26(9):2063–2064, 1999.
  • Barsky AJ; Borus JF. Functional somatic syndromes. Annals of Internal Medicine 130(11):910–921, 1999.
  • Barth H; Berg PA; Klein R. Is there any relationship between eosinophilia myalgia syndrome (EMS) and fibromyalgia syndrome (FMS)? An analysis of clinical and immunological data. Advances in Experimental Medical Biology 467:487–496, 1999.
  • Barth WF. Office evaluation of the patient with musculoskeletal complaints. American Journal of Medicine 102(1A):3S-10S, 1997.
  • Barton A; Pal B; Whorwell PJ; Marshall D. Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. American Journal of Gastroenterology 94(7):1898–1901, 1999.
  • Baschetti R. Etiology of chronic fatigue syndrome. American Journal of Medicine 102(4):422–423, 1997.
  • Baschetti R. Fibromyalgia, chronic fatigue syndrome, and Addison disease. Archives of Internal Medicine 159(20):2481; discussion 2482–2483, 1999.
  • Bassetti S. [A case from practice. Fibromyalgia] Der Fall aus der Prazis (352). Fibromyalgie. Schweize Rundschrift Medizin Prax 85(22):730–731, 1996.
  • Bassoe CF. The skinache syndrome. Journal of the Royal Society of Medicine 88(10): 565–569, 1995.
  • Bassoe CF. [Muscle pain or skin pain?] Muskelverk eller hudverk? Tidsskr Nor Laegeforen 117(18):2649–2650, 1997.
  • Bazelmans E; Vercoulen JH; Galama JM; van Weel C; van der Meer JW; Bleijenberg G. Prevalence of chronic fatigue syndrome and primary fibromyalgia syndrome inthe Netherlands. Nederlands Tijdschrift voor Geneeskunde 141(31):1520–1523, 1997.
  • Bazelmans E; Vercoulen JH; Swanink CM; Fennis JF; Galama JM; van Weel C; van der Meer JW; Bleijenberg G. Chronic Fatigue Syndrome and Primary Fibromyalgia Syndrome as recognized by GPs. Family Practice 16(6):602–604, 1999.
  • Beger CS. The importance of subjective claims management. Benefits Quarterly 13(4):41–45, 1997.
  • Belilos E; Carsons S. Rheumatologic disorders in women. Medicine Clinics of North America 82(1):77–101, 1998.
  • Bell IR; Baldwin CM; Russek LG; Schwartz GE; Hardin EE. Early life stress, negative paternal relationships, and chemical intolerance in middle-aged women: support for a neural sensitization model. Journal of Womens Health 7(9):1135–1147, 1998a.
  • Bell IR; Baldwin CM; Schwartz GE. Illness from low levels of environmental chemi-cals: relevance to chronic fatigue syndrome and fibromyalgia. American Journal of Medicine 105(3A):74S-825, 1998b.
  • Bell IR; Patarca R; Baldwin CM; Klimas NG; Schwartz GE; Hardin EE. Serum neopterin and somatization in women with chemical intolerance, depressives, and normals. Neuropsychobiology 38(1):13–18, 1998c.
  • Bell IR; Szarek MJ; Dicenso DR; Baldwin CM; Schwartz GE; Bootzin RR. Patterns of waking EEG spectral power in chemically intolerant individuals during repeated chemical exposures. International Journal of Neurosciences 97(1-2):41–59, 1999.
  • Bellamy N; Kaloni S; Pope J; Coulter K; Campbell J. Quantitative rheumatology: a survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada. Journal of Rheumatology 25(5):852–858, 1998.
  • Bellamy N; Muirden KD; Brooks PM; Barraclough D; Tellus MiM; Campbell J. A sur-vey of outcome measurement procedures in routine rheumatology outpatient prac-tice in Australia. Journal of Rheumatology 26(7):1593–1599, 1999.
  • Bellometti S; Galzigna L. Function of the hypothalamic adrenal axis in patients with fibromyalgia syndrome undergoing mud-pack treatment. International Journal of Clinical Pharmacology Research 19(1):27–33, 1999.
  • Ben-Zion I: Shieber A; Buskila D. Psychiatric aspects of fibromyalgia syndrome. Harefuah 131(3-4):127–129, 1996.
  • Bendtsen L; Norregaard J; Jensen R; Olesen J. Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis and Rheumatism 40(1):98–102, 1997.
  • Bendtsen L. Central sensitization in tension-type headache-possible pathophysio-logical mechanisms. Cephalalgia 20(5):486–508, 2000.
  • Bengtsson A; Henriksson KG. [Causes of fibromyalgia are both peripheral and central] Fibromyalgins orsaker bade perifera och centrala. Lakartidningen 93(3):161–163, 1996.
  • Benito-Leon J; Berbel A; Porta-Estessam J; Martinez A; Arenas J. [Fibromyalgia in right half of the body as the onset of mitochondrial cytopathy. Letter] Fibromialgia en hemicuerpo derecho como forma de presentacion de una citopatia mitocondrial. Revista Neurologica 24(134):1303–1304, 1996.
  • Benjamin S; Morris S; McBeth J; Macfarlane GJ; Silman AJ. The association between chronic widespread pain and mental disorder: a population-based study. Arthritis and Rheumatism 43(3):561–567, 2000.
  • Bennett AL; Mayes DM; Fagioli LR; Guerriero R; Komaroff AL. Somatomedin C (in-sulin-like growth factor I) levels in patients with chronic fatigue syndrome. Journal of Psychiatric Research 31(1):91–96, 1997.
  • Bennett RM. Fibromyalgia: the commonest cause of widespread pain. Comprehensive Therapy 21(6):269–75, 1995.
  • Bennett RM; Burckhardt CS; Clark SR; O'Reilly CA; Wiens AN; Campbell SM. Group treatment of fibromyalgia: a 6 month outpatient program. Journal of Rheum-atology 23(3):521–528, 1996a.
  • Bennett RM. Multidisciplinary group programs to treat fibromyalgia patients. Rheu-matic Diseases Clinics of North America 22(2):351–367, 1996b.
  • Bennett R. Fibromyalgia, chronic fatigue syndrome, and myofascial pain. Current Opinions in Rheumatology 10(2):95–103, 1998.
  • Bennett RM. Fibromyalgia and the disability dilemma. A new era in understanding a complex, multidimensional pain syndrome. Arthritis and Rheumatism 39(10): 1627–1634, 1996.
  • Bennett RM; Cook DM; Clark SR; Burckhardt CS; Campbell SM. Hypothalamic-pitu-itary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. Journal of Rheumatology 24(7):1384–1389, 1997.
  • Bennett R. The concurrence of lupus and fibromyalgia: implications for diagnosis and management. Lupus 6(6):494–499, 1997.
  • Bennett RM; Clark SC; Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. American Journal of Medicine 104(3):227–231, 1998.
  • Bennett RM. Disordered growth hormone secretion in fibromyalgia: a review of recent findings and a hypothesized etiology. Zeitschrift Rheumatologie 57 Suppl 2:72–76, 1998.
  • Bennett RM. Emerging concepts in the neurobiology of chronic pain: evidence of ab-normal sensory processing in fibromyalgia. Mayo Clinic Proceedings 74(4):385–398, 1999.
  • Berg D; Berg LH; Couvaras J; Harrison H. Chronic fatigue syndrome and/or fibro-myalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis. Blood Coagulation and Fibrinolysis 10(7):435–438, 1999.
  • Berg JE; Berg 0; Reiten T; Kostveit S. Functional diagnosis as a tool in rehabilitation: a comparison of teachers and other employees. International Journal of Rehabilita-tion Research 21(3):273–284, 1998.
  • Berman BM; Swyers JP. Establishing a research agenda for investigating alternative medical interventions for chronic pain. Primary Care 24(4):743–758, 1997.
  • Berman BM; Swyers JP. Complementary medicine treatments for fibromyalgia syn-drome. Baillieres Best Practice Research in Clinical Rheumatology 13(3):487–492, 1999.
  • Berman BM; Ezzo J; Hadhazy V; Swyers JP. Is acupuncture effective in the treatment of fibromyalgia? Journal of Family Practice 48(3):213–218, 1999.
  • Berman BM; Swyers JP; Ezzo J. The evidence for acupuncture as a treatment for rheumatologic conditions. Rheumatic Disease Clinics of North America 26(1): 103-115, ix-x, 2000.
  • Berman DS; Wenglin BD. Complaints attributed to chronic Lyme disease: depression or fibromyalgia? American Journal of Medicine 99(4):440, 1995.
  • Bernstein WJ. Myofascial pain and fibromyalgia syndromes. Neurology 48(6):1738; discussion 1741–1742, 1997.
  • Bertolin JM; Calvo J. Chronic fatigue syndrome. To be or not to be? Medicina Clinica 108(15):577–579, 1997.
  • Berwaerts J; Moorkens G; Abs R. Secretion of growth hormone in patients with chronic fatigue syndrome. Growth Hormone and IGF Research 8 Suppl B:127-129, 1998.
  • Bessette L; Carette S; Fossel AH; Lew RA. A placebo controlled crossover trial of sub-cutaneous salmon calcitonin in the treatment of patients with fibromyalgia. Scandi-navian Journal of Rheumatology 27(2):112–116, 1998.
  • Biasi G; Manca S; Manganelli S; Marcolongo R. Tramadol in the fibromyalgia syn-drome: a controlled clinical trial versus placebo. International Journal of Clinical Pharmacology Research 18(1):13–19, 1998.
  • Biasi G; Badii F; Magaldi M; Moltoni L; Marcolongo R. [A new approach to the treat-ment of fibromyalgia syndrome. The use of Telo Cypro] Un nuovo approccio al trattamento della sindrome fibromialgica. L'uso del Telo Cypro. Minerva Medica 90(1–2):39-43, 1999.
  • Birdsall TC. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Alterna-tive Medicine Reviews 3(4):271–280, 1998.
  • Blackburn WD Jr; Grotting JC; Everson MP. Lack of evidence of systemic inflamma-tory rheumatic disorders in symptomatic women with breast implants. Plastic and Reconstructive Surgery 99(4):1054–1060, 1997.
  • Blackmore MG; Gladman DD; Husted J; Long JA; Farewell VT. Measuring health sta-tus in psoriatic arthritis: the Health Assessment Questionnaire and its modification. Journal of Rheumatology 22(5):886–893, 1995.
  • Blunt KL; Rajwani MH; Guerriero RC. The effectiveness of chiropractic management of fibromyalgia patients: a pilot study. Journal of Manipulative Physiological Ther-apy 20(6):389–399, 1997.
  • Bohr T. A long-term follow-up on "post-traumatic fibromyalgia" patients. American Journal of Physical Medicine and Rehabilitation 74(6):476–477, 1995.
  • Bohr T. Problems with myofascial pain syndrome and fibromyalgia syndrome. Neu-rology 46(3):593–597, 1996.
  • Bolwijn PH; van Santen-Hoeufft MH; Baars HM; Kaplan CD; van der Linden S. The social network characteristics of fibromyalgia patients compared with healthy con-trols. Arthritis Care Research 9(1):18–26, 1996.
  • Bombardier CH; Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibro-myalgia. Disability and health-care use. Medical Care 34(9):924–930, 1996.
  • Bonaccorso S; Lin AH; Verkerk R; Van Hunsel F; Libbrecht I; Scharpe S; DeClerck L; Biondi M; Janca A; Maes M. Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers. Journal of Affective Disorders 48(1):75–82, 1998.
  • Bondy B; Spaeth M; Offenbaecher M; Glatzeder K; Stratz T; Schwarz M; de Jonge S; Kruger M; Engel RR; Farber L; Pongratz DE; Ackenheil M. The T102C polymor-phism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiological Diseases 6(5):433–439, 1999.
  • Borenstein D. Epidemiology, etiology, diagnostic evaluation, and treatment of low back pain. Current Opinions in Rheumatology 8(2):124–129, 1996.
  • Borg-Stein J; Stein J. Trigger points and tender points: one and the same? Does injec-tion treatment help? Rheumatic Diseases Clinics of North America 22(2):305–322, 1996.
  • Borman P; Celiker R; Hascelik Z. Muscle performance in fibromyalgia syndrome. Rheumatology International 19(1-2):27–30, 1999.
  • Bou-Holaigah I; Calkins H; Flynn JA; Tunin C; Chang HC; Kan JS; Rowe PC. Provo-cation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clinical and Experimental Rheumatology 15(3):239–246, 1997.
  • Bradley LA; Alarcon GS; Aaron LA; Martin MY; Alberts KR; Sotolongo A. Abnor-mal pain perception in patients with fibromyalgia: comment on the article by Bendtsen et al. Arthritis and Rheumatism 40(12):2275–2277, 1997.
  • Bradley LA; Alarcon GS. Is Chiari malformation associated with increased levels of substance P and clinical symptoms in persons with fibromyalgia? Arthritis and Rheumatism 42(12):2731–2732, 1999.
  • Bradley LA; Alberts KR. Psychological and behavioral approaches to pain manage-ment for patients with rheumatic disease. Rheumatic Diseases Clinics of North America 25(1):215-232, viii, 1999.
  • Bradley LA; McKendree-Smith NL; Alarcon GS. Pain Complaints in Patients with Fibromyalgia Versus Chronic Fatigue Syndrome. Current Reviews on Pain 4(2): 148–157, 2000.
  • Bramwell B; Ferguson S; Scarlett N; Macintosh A. The Use of Ascorbigen in the Treatment of Fibromyalgia Patients: A Preliminary Trial. Alternative Medical Re-views 5(5):455–462, 2000.
  • Branco J, Atalaia A; Paiva T. Sleep cycles and alpha-delta sleep in fibromyalgia syn-drome. Journal of Rheumatology 21:1113–1117, 1994.
  • Brattberg G. Connective tissue massage in the treatment of fibromyalgia. European Journal of Pain 3(3):235–244, 1999.
  • Breau LM; McGrath PJ; Ju LH. Review of juvenile primary fibromyalgia and chronic fatigue syndrome. Journal of DevelopmentalBehavioral Pediatrics 20(4):278–288, 1999.
  • Bridges AJ; Anderson JD; Bums DE; Kemple K; Kaplan JD; Lorden T. Auto-antibodies in patients with silicone implants. Current Topics in Microbiology and Immunology 210:317–322, 1996.
  • Briggs FE. Fibromyalgia: an important diagnosis to consider. Nurse Practice 22(8): 27–28, 1997.
  • Brown CR. Fibromyalgia. Practice Periodontics and Aesthetic Dentistry 9(8):878, 883, 1997.
  • Brown SL; Langone JJ; Brinton LA. Silicone breast implants and autoimmune disease. Journal of the American Medical Womens Association 53(1):21–24, 40, 1998.
  • Bruce IN; Mak VC; Hallett DC; Gladman DD; Urowitz MB. Factors associated with fatigue in patients with systemic lupus erythematosus. Annals of Rheumatic Dis-eases 58(6):379–381, 1999.
  • Bryson HM; Wilde MI. Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states. Drugs and Aging 8(6):459–476, 1996.
  • Buchwald D; Pearlman T; Umali J; Schmaling K; Katon W. Functional status in pa-tients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individ-uals. American Journal of Medicine 101(4):364–370, 1996.
  • Buchwald D; Umali J; Stene M. Insulin-like growth factor-I (somatomedin C) levels in chronic fatigue syndrome and fibromyalgia. Journal of Rheumatology 23(4):739–742, 1996.
  • Buchwald D. Fibromyalgia and chronic fatigue syndrome: similarities and differences. Rheumatic Disease Clinics of North America 22(2):219–243, 1996.
  • Buchwald D; Umali J; Pearlman T; Kith P; Ashley R; Wener M. Postinfectious chronic fatigue: A distinct syndrome? Clinical Infectious Diseases 23(2):385–387, 1996.
  • Buchwald D; Ashley RL; Pearlman T; Kith P; Komaroff AL. Viral serologies in pa-tients with chronic fatigue and chronic fatigue syndrome. Journal of Medical Virol-ogy 50(1):25–30, 1996.
  • Buckelew SP; Huyser B; Hewett JE; Parker JC; Johnson JC; Conway R; Kay DR. Self-efficacy predicting outcome among fibromyalgia subjects. Arthritis Care Re-search 9(2):97–104, 1996.
  • Buckelew SP; Conway R; Parker J; Deuser WE; Read J; Witty TE; Hewett JE; Minor M; Johnson JC; Van Male L; McIntosh MJ; Nigh M; Kay DR. Biofeedback/relax-ation training and exercise interventions for fibromyalgia: a prospective trial. Ar-thritis Care Research 11(3):196–209, 1998.
  • Buckwalter JA; Lappin DR: The disproportionate impact of chronic arthralgia and ar-thritis among women. Clinical Orthopedics (372):159–168, 2000.
  • Bujak DI; Weinstein A; Dornbush RL. Clinical and neurocognitive features of the post Lyme syndrome. Journal of Rheumatology 23(8):1392–1397, 1996.
  • Burckhardt CS; Bjelle A. Perceived control: a comparison of women with fibro-myalgia, rheumatoid arthritis, and systemic lupus erythematosus using a Swedish version of the Rheumatology Attitudes Index. Scandinavian Journal of Rheuma-tology 25(5):300–306, 1996.
  • Burckhardt CS; Jones KD; Clark SR. Soft tissue problems associated with rheumatic disease. Lippincotts Primary Care Practice 2(1):20–29; quiz 30–31, 1998.
  • Burgunder JM. Pathophysiology of akinetic movement disorders: a paradigm for stud-ies in fibromyalgia? Zeitschrtft Rheumatologie 57 Suppl 2:27–30, 1998.
  • Buskila D; Neumann L. Assessing functional disability and health status of women with fibromyalgia: validation of a Hebrew version of the Fibromyalgia Impact Questionnaire. Journal of Rheumatology 23(5):903–906, 1996.
  • Buskila D; Neumann L; Hazanov I; Carmi R. Familial aggregation in the fibromyalgia syndrome. Seminars in Arthritis and Rheumatism 26(3):605–611, 1996.
  • Buskila D. Fibromyalgia in children-lessons from assessing nonarticular tenderness. Journal of Rheumatology 23(12):2017–2079, 1996.
  • Buskila D; Neumann L. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. Journal of Rheumatology 24(5):941–944, 1997.
  • Buskila D; Neumann L; Sibirski D; Shvartzman P. Awareness of diagnostic and clini-cal features of fibromyalgia among family physicians. Family Practice 14(3):238–241, 1997.
  • Buskila D; Shnaider A; Neumann L; Zilberman D; Hilzenrat N; Sikuler E. Fibromyal-gia in hepatitis C virus infection. Another infectious disease relationship. Archives of Internal Medicine 157(21):2497–2500, 1997.
  • Buskila D; Zaks N; Neumann L; Livneh A; Greenberg S; Pras M; Langevitz P. Quality of life of patients with familial Mediterranean fever. Clinical and Experimental Rheumatology 15(4):355–360, 1997.
  • Buskila D; Neumann L; Vaisberg G; Alkalay D; Wolfe F. Increased rates of fibromy-algia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis and Rheumatism 40(3):446–452, 1997.
  • Buskila D; Shnaider A; Neumann L; Lorber M; Zilberman D; Hilzenrat N; Kuperman OJ; Sikuler E. Musculoskeletal manifestations and autoantibody profile in 90 hepa-titis C virus infected Israeli patients. Seminars in Arthritis and Rheumatism 28(2): 107–113, 1998.
  • Buskila D. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Current Opinions in Rheumatology 11(2):119–126, 1999.
  • Buskila D; Odes LR; Neumann L; Odes HS. Fibromyalgia in inflammatory bowel dis-ease. Journal of Rheumatology 26(5):1167–1171, 1999.
  • Buskila D. Drug therapy. Baillieres Best Practice Research in Clinical Rheumatology 13(3):479–485, 1999.
  • Buskila D. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Current Opinions in Rheumatology 12(2):113–123, 2000.
  • Buskila D; Neumann L; Alhoashle A; Abu-Shakra M. Fibromyalgia syndrome in men. Seminars in Arthritis and Rheumatism 30(1):47–51, 2000.
  • Buskila D. Hepatitis C-associated arthritis. Current Opinions in Rheumatology 12(4): 295–299, 2000.
  • Butler C; Rollnick S. Missing the meaning and provoking resistance; a case of myalgic encephalomyelitis. Family Practice 1996; 13(1):106–109, 1996.
  • Callahan LF; Blalock SJ. Behavioral and social research in rheumatology. Current Opinion in Rheumatology 9(2):126–132, 1997.
  • Calvo-Alen J; Bastian HM; Straaton KY; Burgard SL; Mikhail IS; Alarcon GS. Identi-fication of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis and Rheumatism 38(10):1475–1484, 1995.
  • Campbell SM; Clark S; Tindall EA; Forehand ME; Bennett RM. Clinical characteris-tics of fibrositis. I. A "blinded," controlled study of symptoms and tender points. Arthritis and Rheumatism 26:817-824, 1983.
  • Cantini F; Salvarani C; Olivieri I; Niccoli L; Padula A; Bellandi F; Palchetti R. Tuber-culous spondylitis as a cause of inflammatory spinal pain: a report of 4 cases. Clini-cal and Experimental Rheumatology 16(3):305–308, 1998.
  • Capen K. The courts, expert witnesses and fibromyalgia. Canadian Medical Associa-tion Journal 153(2):206–208, 1995.
  • Caplan C. Chronic fatigue syndrome or just plain tired? Canadian Medical Association Journal 159(5):519–520, 1998.
  • Cardenal A; Masuda I; Ono W; Haas AL; Ryan LM; Trotter D; McCarty DJ. Serum nu-cleotide pyrophosphohydrolase activity; elevated levels in osteoarthritis, calciumpyrophosphate crystal deposition disease, scleroderma, and fibromyalgia. Journal of Rheumatology 25(11):2175–2180, 1998.
  • Carette S; Oakson G; Guimont C; Steriade M. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis and Rheu-matism 38(9):1211–1217, 1995.
  • Carette S. Chronic pain syndromes. Annals of Rheumatic Diseases 55(8):497–501, 1996.
  • Cassidy JT. Progress in diagnosis and understanding chronic pain syndromes in chil-dren and adolescents. Adolescent Medicine 9(1):101-114, vi, 1998.
  • Cathebras P. [What is a disease?] Qu'est-ce qu'une maladie? Revue Medicine Interne 18(10):809–813, 1997.
  • Cathebras P; Lauwers A; Rousset H. [Fibromyalgia. A critical review] La fibromyalgie.Une revue critique. Annales Medicine Interne (Paris) 149(7):406–414, 1998. Cathebras P. [Should fibromyalgia survive the century?] La fibromyalgie doit-ellepasser le siecle? Revue Medicale Interne 21(7):577–579, 2000.
  • Celiker R; Borman P; Oktem F; Gokce-Kutsal Y; Basgoze O. Psychological distur-bance in fibromyalgia: relation to pain severity. Clinical Rheumatology 16(2):179–184, 1997.
  • Chalder T; Power MJ; Wessely S. Chronic fatigue in the community: a question of at-tribution. Psychological Medicine 26(4):791–800, 1996.
  • Chambers CR. Fireworks over fibromyalgia, CFS, and IBS. Postgraduate Medicine 102(6):43, 1997.
  • Chambliss ML. Are serotonin uptake inhibitors useful in chronic pain syndromes such as fibromyalgia or diabetic neuropathy? Archives of Family Medicine 7(5):470–471, 1998.
  • Chang L. The association of functional gastrointestinal disorders and fibromyalgia. European Journal of Surgery Suppl (583):32–36, 1998.
  • Chang L; Mayer EA; Johnson T; FitzGerald LZ; Naliboff B. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 84(2-3):297–307, 2000.
  • Cherin P; Authier FJ; Gherardi RK; Romero N; Laforet P; Eymard B; Herson S; Caillat-Vigneron N. Gallium-67 scintigraphy in macrophagic myofascitis. Arthritis and Rheumatism 43(7):1520–1526, 2000.
  • Chester AC: Chronic fatigue syndrome criteria in patients with other forms of unex-plained chronic fatigue. Journal of Psychiatric Research 31(1):45–50, 1997.
  • Cheung F; Lin KM: Neurasthenia, depression and somatoform disorder in a Chi-nese-Vietnamese woman migrant. Culture, Medicine & Psychiatry 1997; 21(2): 247–258.
  • Choppa PC; Vojdani A; Tagle C; Andrin R; Magtoto L. Multiplex PCR for the detec-tion of Mycoplasma fermentans, M. hominis and M. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome. Molecular & Cellular Probes 12(5):301–308, 1998.
  • Chronic fatigue syndrome. Baschetti R. Journal of the American Medical Association 279(6):431–433, 1998; Quarterly Journal of Medicine 90(11):723, 1997; Chester AC Journal of the American Medical Association 279(6):432–3, 1998; Czarnowski D, Panasiuk B, Wiercinska-Drapalo A, Puzanowska B, Prokopowicz D. PolskieArchiwum Medycyny Wewnetrznej 96(2):161–164, 1996; David A, Wessely S. Lan-cet 348(9038):1385, 1996; Demitrack MA, Engleberg NC. Current Therapy in En-docrinology & Metabolism 6:152-160, 1997; Devitt NF JAMA 279(6):432; discussion 432–433, 1997; Egyedi P. Nederlands Tijdschrtft voor Geneeskunde 141(37): 1790–1791, 1997; Fisher L. Professional Nurse 12(8):578–581, 1997; Hedrick TE QJM 90(11):723–725, 1997; Knepper S. Nederlands Tijdschrtft voor Geneeskunde 141(48):2360, 1997; Kende11 R, Tumberg L, Toby J. Lancet 348(9038):1384, 1996; Koehoorn J, Fechter MM, de Vries H. Nederlands Tijdschrift voor Geneeskunde 141(48):2362–2363, 1997; Kroneman H, Croon NH. Nederlands Tijdschrift voor Geneeskunde 141(37):1791, 1997; Litzman J, Lokaj J, Fucikova T. Casopis Lekaru Ceskych 137(10):295–298, 1998; Loblay RH. Lancet 351(9111):1292, 1998; Mawle AC. Immunological Investigations 26(1–2):269-273, 1997; Mayou R. Lancet 348(9038):1384–1385, 1996; Rouillon F, Delhommeau L, Vinceneux P. Presse Medicale 25(40):2031–2036, 1996; Sharpe M. Psychiatric Clinics of North Amer-ica 19(3):549–573, 1996; Shepherd C. Professional Nurse 12(11):827, 1997; Shep-herd C. Lancet 349(9044):57–58, 1997; Smits MG, Nagtegaal JE, Swart AC. Nederlands Ttjdschnft voor Geneeskunde 141(48):2359–2360, 1997; Sobetzko HM, Stark FM. Nervenarzt 68(11):924–925, 1997; Straus SE BMJ 313(7061): 831–832, 1996; Studd J, Panay N. Lancet 348(9038):1384, 1996; Sykes R. Br J Psy-chiatry 171:393, 1997; van der Meer JW. Nederlands Tijdschrift voor Geneeskunde 141(31):1507–1509, 1997; van der Meer JVV. Eur J Clin Investig 27(4):255–256, 1997; Van Dishoeck EA. Nederlands Tijdschrift voor Geneeskunde 141(48): 2358–2359, 1997; Van Houdenhove B, Fischler B, Neerinckx E. Nederlands Tijdschrtft voor Geneeskunde 141(48):2360–2361, 1997; Vooren PH. Nederlands Tijdschrtft voor Geneeskunde 141(48):2359, 1997; Wijlhuizen T, Hamerslag M. Nederlands Tijdschrift voor Geneeskunde 141(48):2361–2362, 1997.
  • Chu J. The role of the monopolar electromyographic pin in myofascial pain therapy: automated twitch-obtaining intramuscular stimulation (ATOWIS) and electrical twitch-obtaining intramuscular stimulation (ETOIMS). Electromyography and Clin-ical Neurophysiology 39(8):503–511, 1999.
  • Chu J. Early observations in radiculopathic pain control using electrodiagnostically derived new treatment techniques: automated twitch-obtaining intramuscular stim-ulation (ATOIMS) and electrical twitch-obtaining intramuscular stimulation (ETOIMS). Electromyography and Clinical Neurophysiology 40(4):195–204, 2000.
  • Chun A; Desautels S; Slivka A; Mitrani C; Starz T; DiLorenzo C; Wald A. Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of oddi dysfunc-tion, type III. Digestive Disease Sciences 44(3):631–636, 1999.
  • Cimino R; Michelotti A; Stradi R; Farinaro C. Comparison of clinical and psychologic features of fibromyalgia and masticatory myofascial pain. Journal of Orofacial Pain 12(1):35–41, 1998.
  • Cimmino MA; Parisi M; Moggiana G; Accardo S. The association between fibro-myalgia and carpal tunnel syndrome in the general population. Annals of Rheumatic Diseases 55(10):780, 1996.
  • Citera G; Arias MA; Maldonado-Cocco JA; Lazaro MA; Rosemffet MG; Brusco LI; Scheines EJ; Cardinalli DP. The effect of melatonin in patients with fibromyalgia: a pilot study. Clinical Rheumatology 19(1):9–13, 2000.
  • Clark P; Burgos-Vargas R; Medina-Palma C; Lavielle P; Marina FF. Prevalence of fibromyalgia in children: a clinical study of Mexican children. Journal of Rheuma-tology 25(10):2009–2014, 1998.
  • Clauw D; Blank C; Hiltz R; Katz P; Potolicchio S. Polysomnography in fibromyalgia patients. Arthritis and Rheumatism 37 Suppl. 9:S348, 1994.
  • Clauw DJ. Fibromyalgia: more than just a musculoskeletal disease. American Family Physician 52(3):843–51, 853–854, 1995.
  • Clauw DJ; Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmuno-modulation 4(3):134–153, 1997.
  • Clauw DJ; Schmidt M; Radulovic D; Singer A; Katz P; Bresette J. The relationship be-tween fibromyalgia and interstitial cystitis. Journal of Psychiatric Research 31(1): 125–131, 1997.
  • Clauw DJ. Treating fibromyalgia: science vs. art. American Family Physician 62(7): 1492, 1494, 2000.
  • Cohen H; Neumann L; Shore M; Amir M; Cassuto Y; Buskila D. Autonomic dysfunc-tion in patients with fibromyalgia: application of power spectral analysis of heart rate variability. Seminars in Arthritis and Rheumatism 29(4):217–227, 2000.
  • Cohen ML; Quintner JL. Fibromyalgia syndrome and disability: a failed construct fails those in pain. Medical Journal of Australia 168(8):402–404, 1998.
  • Cohen ML; Quintner JL. Altered nociception, but not fibromyalgia, after cervical spine injury: comment on the article by Buskila et al. Arthritis and Rheumatism 41(1):183–184, 1998.
  • Cohen ML. Is fibromyalgia a distinct clinical entity? The disapproving rheuma-tologist' s evidence. Baillieres Best Practice Research in Clinical Rheumatology 13(3):421–425, 1999.
  • Cohn U. Management of fibromyalgia. Annals of Internal Medicine 132(12):1005, 2000.
  • Cole SW; Kemeny ME; Weitzman OB; Schoen M; Anton PA. Socially inhibited indi-viduals show heightened DTH response during intense social engagement. Brain, Behavior and Immunity 13(2):187–200, 1999.
  • Cook NF; Boore JR. Managing patients suffering from acute and chronic fatigue. Brit-ish Journal of Nursing 6(14):811–815, 1997.
  • Coplan JD; Tamir H; Calaprice D; DeJesus M; de la Nuez M; Pine D; Papp LA; Klein DF; Gorman JM. Plasma anti- serotonin and serotonin anti-idiotypic antibodies are elevated in panic disorder. Neuropsychopharmacology 20(4):386–391, 1999.C-ote KA; Moldofsky H. Sleep, daytime symptoms, and cognitive performance in pa-tients with fibromyalgia. Journal of Rheumatology 24(10):2014–2023, 1997. Coward BL. Clinical snapshot. Fibromyalgia. American Journal of Nursing 99(10):42–43, 1999.
  • Crofford LJ; Demitrack MA. Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome. Rheumatic Diseases Clinics of North America 22(2):267–284, 1996.
  • Crofford LJ; Engleberg NC; Demitrack MA. Neurohormonal perturbations in fibro-myalgia. Baillieres Clinical Rheumatology 10(2):365–378, 1996.
  • Crofford U. Neuroendocrine abnormalities in fibromyalgia and related disorders. American Journal of Medical Sciences 315(6):359–366, 1998.
  • Crofford U. The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome. Zeitschrift Rheumatologie 57 Suppl 2:67–71, 1998.
  • Croft P; Schollum J; Silman A. Population study of tender point counts and pain as evi-dence of fibromyalgia. British Medical Journal 309:696–699, 1994.
  • Croft P; Burt J; Schollum J; Thomas E; Macfarlane G; Silman A. More pain, more ten-der points: is fibromyalgia just one end of a continuous spectrum? Annals of Rheu-matic Diseases 55(7):482–485, 1996.
  • Crook J; Moldofsky H; Shannon H. Determinants of disability after a work related musculoskeletal injury. Journal of Rheumatology 25(8):1570–1577, 1998.
  • Csef H. [The non-specific environmental syndromes MCS (Multiple Chemical Sensi-tivity), lEI (Idiopathic Environmental Intolerance) and SBS (Sick Building Syn-drome)] Die unspezifischen Umweltsyndrome MCS, 1E1 und SBS. Klinische Bilder und Therapieansatze. Fortschrift Medizin 116(33):18–20, 22, 24, 1998.
  • Csef H. [Similarities of chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivity] Gemeinsamkeiten von Chronic Fatigue Syndrome, Fibromyalgie und multipler chemischer Sensitivitat. Deutsche Medizin Wochenschrtft 124(6):163–169, 1999.
  • Cuellar ML; Gluck 0; Molina JF; Gutierrez S; Garcia C; Espinoza R. Silicone breast implant-associated musculoskeletal manifestations. Clinical Rheumatology 14(6): 667–672, 1995.
  • Cunningham ME. Becoming familiar with fibromyalgia. Orthopedic Nursing 15(2): 33–36, 1996.
  • Da Costa D; Dobkin PL; Fitzcharles MA; Fortin PR; Beaulieu A; Zummer M; Senecal IL; Goulet JR; Rich E; Choquette D; Clarke AE. Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. Journal of Rheumatology 27(2):365–372, 2000.
  • Dao TT; Reynolds WJ; Tenenbaum HC. Comorbidity between myofascial pain of the masticatory muscles and fibromyalgia. Journal of Orofacial Pain 11(3):232–241, 1997.
  • Dao T; Reynolds WJ; Tenenbaum HC. Comorbidity between myofascial pain of the masticatory muscles and fibromyalgia. Alpha Omegan 91(2):29–37, 1998. de Jesus M. Fibromyalgia onset. American Journal of Nursing 100(1):14, 2000.
  • De Laat A. [Etiologic factors in temporomandibular joint disorders and pain] Facteurs etiologiques dans les troubles et l'algie temporo-mandibulaires. Revue Beige de Medicine Dentale 52(4):115–123, 1997.
  • de Loos WS: Chronic fatigue syndrome: Fatigue of unknown origin. European Jour-nal of Clinical Investigation 27(4):268–269, 1997.
  • De Lorenzo F; Hargreaves J; Kakkar VV. Phosphate diabetes in patients with chronic fatigue syndrome. Postgraduate Medical Journal 74(870):229–232, 1998.
  • De Tomas Palacios J; Sanchez Sabate E; Turegano Fuentes F; Zabay TM. [Retro-peritoneal leiomyosarcoma in a patient with fibromyalgia] Leiomiosarcoma retro-peritoneal en una paciente con fibromialgia. Anales de Medicina Interna 12(12): 617–618, 1995.
  • Delbanco TL; Daley J; Hartman EE. A 56-year-old woman with chronic fatigue syn-drome, 1 year later. Journal of the American Medical Association 280(4):372, 1998.
  • DeLuca J; Johnson SK; Ellis SP; Natelson BH. Sudden vs. gradual onset of chronic fa-tigue syndrome differentiates individuals on cognitive and psychiatric measures. Journal of Psychiatric Research 31(1):83–90, 1997.
  • Demitrack MA. Neuroendocrine correlates of chronic fatigue syndrome: a brief re-view. Journal of Psychiatric Research 31(1):69–82, 1997.
  • Demitrack MA. Chronic fatigue syndrome and fibromyalgia. Dilemmas in diagnosis and clinical management. Psychiatry Clinics of North America 21(3):671-692, viii, 1998.
  • Demitrack MA; Crofford U. Evidence for and pathophysiologic implications of hypo-thalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Annals of the New York Academy of Sciences 840:684–697, 1998.
  • Dessein PH; Shipton EA; Joffe BI; Hadebe DP; Stanwix AE; Van der Merwe BA. Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, se-rotonin and insulin-like growth factor-1 to clinical features in women with fibro-myalgia. Pain 83(2):313–319, 1999.
  • Des sein PH; Shipton EA; Stanwix AE; Joffe BI. Neuroendocrine deficiency-mediated development and persistence of pain in fibromyalgia: a promising paradigm? Pain 86(3):213–215, 2000.
  • Dessein PH; Stanwix AE. Why would fibromyalgia patients have osteoporosis? Jour-nal of Rheumatology 27(7):1816–1817, 2000.
  • Deuster PA. Exercise in the prevention and treatment of chronic disorders. Womens Health Issues 6(6):320–331, 1996.
  • Dickinson CJ. Chronic fatigue syndrome a aetiological aspects. European Journal of Clinical Investigation 27(4):257–267, 1997.
  • Dimmonck S; Troughton PR; Bird HA. Factors predisposing to the resort of comple-mentary therapies in patients with fibromyalgia. Clinical Rheumatology 15(5): 478–482, 1996.
  • Dinser R; Halama T; Hoffmann A. Stringent endocrinological testing reveals subnor-mal growth hormone secretion in some patients with fibromyalgia syndrome but rarely severe growth hormone deficiency. Journal of Rheumatology 27(10):2482–2488, 2000.
  • Dohrenbusch R; Gruterich M; Genth E. [Fibromyalgia and Sjogren syndrome-clinical and methodological aspects] Fibromyalgie und Sjogren-Syndrom-klinische und methodische Aspekte. Zeitschrtft Rheumatologie 55(1):19–27, 1996.
  • Dohrenbusch R; Sodhi H; Lamprecht J; Genth E. Fibromyalgia as a disorder of percep-tual organization? An analysis of acoustic stimulus processing in patients with widespread pain. Zeitschrift Rheumatologie 56(6):334–341, 1997.
  • Dominick KL; Gullette EC; Babyak MA; Mallow KL; Sherwood A; Waugh R; Chilikuri M; Keefe FJ; Blumenthal JA. Predicting peak oxygen uptake among older patients with chronic illness. Journal of Cardiopulmonary Rehabilitation 19(2): 81–89, 1999.
  • Prevalence of leisure-time physical activity among persons with arthritis and other rheumatic conditions-United States, 1990–1991. MMWR Morbidity and Mortality Weekly Report 46(18):389–393, 1997.
  • Proceedings of the International Fibromyalgia Conference. Bad Nauheim, Germany, October 1997. Zeitschrtft Rheumatologie 57 Suppl 2:V-X, 1–108, 1998.
  • Quang-Cantagrel ND; Wallace MS; Magnuson SK. Opioid substitution to improve the effectiveness of chronic noncancer pain control: a chart review. Anesthedia and An-algesia 90(4):933–937, 2000.
  • Quick DC. Joint pain and weather. A critical review of the literature. Minnesota Medi-cine 80(3):25–29, 1997.
  • Quijada-Carrera J; Valenzuela-Castano A; Povedano-Gomez J; Fernandez-Rodriguez A; Hernanz-Mediano W; Gutierrez-Rubio A; de la Iglesia-Salgado JL; Garcia-Lopez A. Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. Pain 65(2-3):221–225, 1996.
  • Quimby LG; Block SR; Gratwick GM. What use are fibromyalgia control points? Journal of Rheumatology 25(12):2476, 1998.
  • Quintner JL; Cohen ML. Fibromyalgia syndrome. Medical Journal of Australia 166(3):168, 1997.
  • Quintner JL; Cohen ML. Fibromyalgia falls foul of a fallacy. Lancet 353(9158): 1092–1094, 1999.
  • Rahn DW; Felz MW. Lyme disease update. Current approach to early, disseminated, and late disease. Postgraduate Medicine 103(5):51–54, 57–59, 63–64 passim, 1998.
  • Ramsay C; Moreland J; Ho M; Joyce S; Walker S; Pullar T. An observer-blinded com-parison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford) 39(5):501–505, 2000.
  • Rankin DB. The fibromyalgia syndrome: a consensus report. New Zealand Medical Journal 112(1080):18–19, 1999.
  • Rao JK; Mihaliak K; Kroenke K; Bradley J; Tierney WM; Weinberger M. Use of com-plementary therapies for arthritis among patients of rheumatologists. Annals of In-ternal Medicine 131(6):409–416, 1999.
  • Raphael KG; Marbach JJ. Comorbid fibromyalgia accounts for reduced fecundity in women with myofascial face pain. Clinical Journal of Pain 16(1):29–36, 2000.
  • Raphael KG; Marbach JJ; Klausner J. Myofascial face pain. Clinical characteristics of those with regional vs. widespread pain. Journal of the American Dental Associa-tion 131(2):161–171, 2000.
  • Raspe H; Croft P. Fibromyalgia. Baillieres Clinical Rheumatology 9(3):599-614, 1995.
  • Raspe H. [Fibromyalgia-an artifact?] Fibromyalgie-ein Artefakt?Zeitschrift Rheuma-tologie 55(1):1–3, 1996.
  • Rau Cl; Russell IJ. Is Fibromyalgia a Distinct Clinical Syndrome? Current Reviews in Pain 4(4):287–294, 2000.
  • Raymond MC; Brown JB. Experience of fibromyalgia. Qualitative study. Canadian Family Physician 46:1100–1106, 2000.
  • Rea T; Russo J; Katon W; Ashley RL; Buchwald D. A prospective study of tender points and fibromyalgia during and after an acute viral infection. Archives of Inter-nal Medicine 159(8):865–870, 1999.
  • Ream E; Richardson A. Fatigue: A concept analysis. International Journal of Nursing Studies 33(5):519–529, 1996.
  • Reginato AJ; Falasca GF; Pappu R; McKnight B; Agha A. Musculoskeletal manifesta-tions of osteomalacia: report of 26 cases and literature review. Seminars in Arthritis and Rheumatism 28(5):287–304, 1999.
  • Regland B; Andersson M; Abrahamsson L; Bagby J; Dyrehag LE; Gottfries CG. In-creased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scandinavian Journal of Rheuma-tology 26(4):301–307, 1997.
  • Reid GJ; Lang BA; McGrath PJ. Primary juvenile fibromyalgia: Psychological adjust-ment, family functioning, coping, and functional disability. Arthritis & Rheuma-tism 40(4):752–760, 1997.
  • Reiffenberger DH; Amundson LH. Fibromyalgia syndrome: a review. American Fam-ily Physician 53(5):1698–1712, 1996.
  • Reilly PA; Littlejohn GO. Diurnal variation in symptoms and signs of the fibromyalgia syndrome (FS). Journal of Musculoskeletal Pain 1:237–243, 1993.
  • Reilly PA. The differential diagnosis of generalized pain. Baillieres Best Practice Re-search in Clinical Rheumatology 13(3):391–401, 1999.
  • Reilly PA. How should we manage fibromyalgia? Annals of Rheumatic Diseases 58(6):325–326, 1999.
  • Reinhard P; Schweinsberg F; Wernet D; Kotter I. Selenium status in fibromyalgia. Toxicology Letters 96–97:177-180, 1998.
  • Reinhold-Keller E. [Diagnosis of fibromyalgia syndrome] Diagnose de Fibromy-algiesyndroms. Internist (Berl) 38(10):993–994, 1997.
  • Rekola KE; Levoska S; Takala J; Keinanen-Kiukaanniemi S. Patients with neck and shoulder complaints and multisite musculoskeletal symptoms-a prospective study. Journal of Rheumatology 24(12):2424–2428, 1997.
  • Reveille JD. Soft-tissue rheumatism: diagnosis and treatment. American Journal of Medicine 102(1A):235-295, 1997.
  • Reynolds WJ. Fibromyalgia 20 years later; what have we really accomplished? Jour-nal of Rheumatology 23(1):192; discussion 193–194, 1996.
  • Richards S; Cleare A. Treating fibromyalgia. Rheumatology (Oxford) 39(4):343–346, 2000.
  • Ridgway K. Acupuncture as a treatment modality for back problems. Veterinary Clinics of North America and Equine Practice 15(1):211–221, 1999.
  • Riedel W; Layka H; Neeck G. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Zeitschnft Rheumatologie 57 Suppl 2:81–87, 1998.
  • Rivera J; de Diego A; Trinchet M; Garcia Monforte A. Fibromyalgia-associated hepa-titis C virus infection. British Journal of Rheumatology 36(9):981–985, 1997.
  • Robb-Nicholson C. Tread in your June 1997 publication that one of the risk factors for hip fracture is current use of long-acting benzodiazepines. Could you list exactly which medications these are? I take Xanax and doxepin for fibromyalgia. My phar-macist could find no evidence that either of these drugs depletes bone calcium. Howdo they place me at increased risk for osteoporosis? Harvard Womens Health Watch 5(5):8, 1998.
  • Robbins JM; Kirmayer LJ; Hemami S. Latent variable models of functional somaticdistress. Journal of Nervous and Mental Disorders 185(10):606–615, 1997. Robertson TJ. Misunderstood illnesses: fibromyalgia and chronic fatigue syndrome.Alta RN 55(3):6–7, 1999.
  • Rocca PV. Fibromyalgia: how disabling? Delaware Medical Journal 71(6):263–265, 1999.
  • Roizenblatt S; Tufik S; Goldenberg J; Pinto LR; Hilario MO; Feldman D. Juvenile fibromyalgia: clinical and polysomnographic aspects. Journal of Rheumatology 24(3):579–585, 1997.
  • Roizenblatt S; Moldofsky H; Benedito-Silva AA; Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis and Rheumatism 44(1):222–230, 2001.
  • Romano TJ. Fibromyalgia prevalence in patients with systemic lupus erythematosus: comment on the article by Middleton et al. Arthritis and Rheumatism 38(6):872, 1995.
  • Romano TJ. Breast implants and connective-tissue disease. Journal of the American Medical Association 276(2):102; discussion 103, 1996.
  • Romano TJ. Controlled study on serum insulin-like growth factor I and urinary excre-tion of growth hormone in fibromyalgia. Journal of Rheumatology 23(1):194, 1996. Romano TJ. Fibromyalgia 20 years later: what have we really accomplished? Journalof Rheumatology 23(1):192; discussion 193–194, 1996.
  • Romano TJ. Myofascial pain and fibromyalgia syndrome. Neurology 48(6):1739–1740; discussion 1741–1742, 1997.
  • Romano TJ. Possible concomitant fibromyalgia in systemic lupus erythematosus pa-tients with overt central nervous system disease but with cognitive deficits: com-ment on the article by Kozora et al. Arthritis and Rheumatism 40(8):1544–1545, 1997.
  • Romano TJ. The fibromyalgia problem. Journal of Rheumatology 25(5):1026–1027; discussion 1028–1030, 1998.
  • Romano TJ. Patients with fibromyalgia must be treated fairly. Archives of Internal Medicine 159(20):2481–2483, 1999.
  • Rosenberg NL. The neuromythology of silicone breast implants. Neurology 46(2): 308–314, 1996.
  • Rosenfeld WD; Walco GA. One Test Too Many: Toward an integrated approach to psychosomatic disorders. Adolescent Medicine 8(3):483–487, 1997.
  • Rosenhall U; Johansson G; Orndahl G. Otoneurologic and audiologic findings in fibromyalgia. Scandinavian Journal of Rehabilitative Medicine 28(4):225–232, 1996.
  • Ross E. The history and treatment of chronic fatigue syndrome. Nursing Times 92(44):34–36, 1996.
  • Rossy LA; Buckelew SP; Don N; Hagglund KJ; Thayer JF; McIntosh MJ; Hewett JE; Johnson JC. A meta-analysis of fibromyalgia treatment interventions. Annals of Be-havioral Medicine 21(2):180–191, 1999.
  • Rothschild BM. Zolpidem efficacy in fibromyalgia. Journal of Rheumatology 24(5): 1012–1013, 1997.
  • Rowat SC. Paraoxonase/MCS. Environmental Health Perspectives 107(8):A395, 1999. Rubio Montanes ML; Prat Gil N; Adalid Villar C; Pueyo Anton L. [Prevalence of gen-eralized pain of the locomotor system] Prevalencia del dolor generalizado delaparato locomotor. Atencion Primaria 16(6):379–380, 1995.
  • Ruderman EM; Golden HE. Psychiatric diagnoses in patients with fibromyalgia: com-ment on the article by Aaron et al. Arthritis and Rheumatism 39(12):2086–2087, 1996.
  • Ruiz Moral R; Munoz Alamo M; Perula de Torres L; Aguayo Galeote M. Bio-psychosocial features of patients with widespread chronic musculoskeletal pain in family medicine clinics. Family Practice 14(3):242–248, 1997.
  • RuofJ; Hulsemann IL; Stucki G. Evaluation of costs in rheumatic diseases: a literature review. Current Opinions in Rheumatology 11(2):104–109, 1999.
  • Russell AS. Effect of gamma-hydroxybutyrate on pain, fatigue, and alpha sleep anom-aly in patients with fibromyalgia. Journal of Rheumatology 26(12):2712, 1999.
  • Russell IJ; Michalek JE; Flechas JD; Abraham GE. Treatment of fibromyalgia syn-drome with Super Malic: a randomized, double blind, placebo controlled, crossover pilot study. Journal of Rheumatology 22(5):953–958, 1995.
  • Russell U. Fibromyalgia syndrome: approaches to management. Bulletin of Rheumatic Diseases 45(3):1–4, 1996.
  • Russell U. Neurochemical pathogenesis of fibromyalgia. Zeitschrift Rheumatologie 57 Suppl 2:63–66, 1998.
  • Russell IJ. Advances in fibromyalgia: possible role for central neurochemicals. Ameri-can Journal of Medical Sciences 315(6):377–384, 1998.
  • Russell IJ; Vipraio GA; Michalek JE; Craig FE; Kang YK; Richards AB. Lymphocyte markers and natural killer cell activity in fibromyalgia syndrome: effects of low-dose, sublingual use of human interferon-alpha. Journal of Interferon and Cytokine Research 19(8):969–978, 1999.
  • Russell IJ. Is fibromyalgia a distinct clinical entity? The clinical investigator's evi-dence. Baillieres Best Practice Research in Clinical Rheumatology 13(3):445–454, 1999.
  • Russell IJ; Michalek JE; Kang YK; Richards AB. Reduction of morning stiffness and improvement in physical function in fibromyalgia syndrome patients treated sub-lingually with low doses of human interferon-alpha. Journal of Interferon and Cytokine Research 19(8):961–968, 1999.
  • Rusy LM; Harvey SA; Beste DJ. Pediatric fibromyalgia and dizziness: evaluation of vestibular function. Journal of Developmental Behavioral Pediatrics 20(4):211–215, 1999.
  • Rutten-van Molken MP; Bakker CH; van Doorslaer EK; van der Linden S. Method-ological issues of patient utility measurement. Experience from two clinical trials. Medical Care 33(9):922–937, 1995.
  • Ryan S. Fibromyalgia: what help can nurses give? Nursing Stand 9(37):25–28, 1995. Sabal N. Fireworks over fibromyalgia, CFS, and IBS. Postgraduate Medicine 102(6): 44, 1997.
  • Safran S. Lack of control group deemed problematic in fibromyalgia pilot study. Alter-native Therapy Health Medicine 4(5):114, 116, 1998.
  • Salerno A; Thomas E; Olive P; Blotman F; Picot MC; Georgesco M. Motor cortical dysfunction disclosed by single and double magnetic stimulation in patients with fibromyalgia. Clinical Neurophysiology 111(6):994–1001, 2000.
  • Salit IE. The chronic fatigue syndrome: a position paper. J Rheumatol 23(3):540–544, 1996.
  • Salit IE. Precipitating factors for the chronic fatigue syndrome. Journal of Psychiatric Research 31(1):59–65, 1997.
  • Samborski W; Lacki JK; Wiktorowicz KE. The lymphocyte phenotype in patients with primary fibromyalgia. Upsala Journal of Medical Sciences 101(3):251–256, 1996.
  • Samborski W; Stratz T; Schochat T; Mennet P; Muller W. [Biochemical changes in fibromyalgia] Biochemische Veranderungen bei der Fibromyalgie. Zeitschrift Rheumatologie 55(3):168–173, 1996.
  • Samborski W; Stratz T; Lacki JK; Klama K; Mennet P; Muller W. The 5-HT3 blockers in the treatment of the primary fibromyalgia syndrome: a 10-day open study with Tropisetron at a low dose. Mater Med Pol 28(1):17–19, 1996.
  • San Pedro EC; Mountz TM; Mountz JD; Liu HG; Katholi CR; Deutsch G. Familial painful restless legs syndrome correlates with pain dependent variation of blood flow to the caudate, thalamus, and anterior cingulate gyrus. Journal of Rheuma-tology 25(11):2270–2275, 1998.
  • Sandstrom MJ; Keefe FJ. Self-management of fibromyalgia: the role of formal coping skills training and physical exercise training programs. Arthritis Care Research 11(6):432–447, 1998.
  • Sann H; Pierau FK. Efferent functions of C-fiber nociceptors. Zeitschrift Rheuma-tologie 57 Suppl 2:8–13, 1998.
  • Sardini S; Ghirardini M; Betelemme L; Arpino C; Fatti F; Zanini F. [Epidemiological study of a primary fibromyalgia in pediatric age] Studio epidemiologico sulla fibromialgia primaria in eta pediatrica. Minerva Pediatrica 48(12):543–550, 1996.
  • Sarnoch H; Adler F; Scholz OB. Relevance of muscular sensitivity, muscular activity, and cognitive variables for pain reduction associated with EMG biofeedback in fibromyalgia. Perception and Motor Skills 84(3 Pt 1):1043–1050, 1997.
  • Saran JS. Fibromyalgia and pain management. Mayo Clinic Proceedings 75(3): 316–317, 2000.
  • Savelkoul M; Post MW; de Witte LP; van den Borne HB. Social support, coping and subjective well-being in patients with rheumatic diseases. Patient Education and Counseling 39(2-3):205–18, 2000.
  • Schachna L; Littlejohn G. Primary care and specialist management options. Baillieres Best Practice Research in Clinical Rheumatology 13(3):469–477, 1999.
  • Schadrack J; Zieglgansberger W. Pharmacology of pain processing systems. Zeitschrift Rheumatologie 57 Suppl 2:1–4, 1998.
  • Schaefer KIVI. Sleep disturbance and fatigue in women with fibromyalgia and chronic fatigue syndrome. Journal of Obstetrics, Gynecology and Neonatal Nursing 24: 229–233, 1995.
  • Schaefer KIVI. Health patients of women with fibromyalgia. Journal of Advanced Nursing 26(3):565–571, 1997.
  • Schanberg LE; Keefe FJ; Lefebvre JC; Kredich DW; Gil KIVI. Pain coping strategies in children with juvenile primary fibromyalgia syndrome: correlation with pain, phys-ical function, and psychological distress. Arthritis Care Research 9(2):89–96, 1996.
  • Schanberg LE; Keefe FJ; Lefebvre JC; Kredich DW; Gil KIVI. Social context of pain in children with juvenile primary fibromyalgia syndrome: parental pain history and family environment. Clinical Journal of Pain 14(2):107–115, 1998.
  • Scharf MB; Hauck M; Stover R; McDannold M; Berkowitz D. Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report. Journal of Rheumatology 25(10):1986–1990, 1998.
  • Schedule for rating disabilities; fibromyalgia. Department of Veterans Affairs (VA). Final rule. Federal Registry 64(116):32410–32411, 1999.
  • Schepelmann K; Dannhausen M; Kotter I; Schabet M; Dichgans J. Exteroceptive sup-pression of temporalis muscle activity in patients with fibromyalgia, tension-type headache, and normal controls. Elect roencephalography and Clinical Neurophys-iology 107(3):196–199, 1998.
  • Schikler KN. Is it juvenile rheumatoid arthritis or fibromyalgia? Medicine Clinics of North America 84(4):967–982, 2000.
  • Schlenk EA; Erlen JA; Dunbar-Jacob J; McDowell J; Engberg S; Sereika SM; Rohay TM; Bernier MJ. Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Quality of Life Research 7(1):57–65, 1998.
  • Schlienger JL; Goichot B. [Growth hormone: a magical potion?] Hormone de croissance: potion magique? Revue Medicine Interne 19(4):279–285, 1998.
  • Schneider MJ. Tender points/fibromyalgia vs. trigger points/myofascial pain syn-drome: a need for clarity in terminology and differential diagnosis. Journal of Ma-nipulative Physiology Therapy 18(6):398–406, 1995.
  • Schneider M. The effectiveness of chiropractic management of fibromyalgia patients. Journal of Manipulative Physiological Therapy 21(4):307, 1998.
  • Schuck JR; Chappell LT; Kindness G. Causal modeling and alternative medicine. Al-ternative Therapy Health Medicine 3(2):40–47, 1997.
  • Schwarz MJ; Spath M; Muller-Bardorff H; Pongratz DE; Bondy B; Ackenheil M. Re-lationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosciences Letters 259(3):196–198, 1999.
  • Scott LV; Dinan TG. The neuroendocrinology of chronic fatigue syndrome: focus on the hypothalamic-pituitary-adrenal axis. Functional Neurology 14(1):3–11, 1999.
  • Scudds RA; Janzen V; Delaney G; Heck C; McCain GA; Russell AL; Teasell RW; Varkey G; Woodbury MG. The use of topical 4% lidocaine in spheno-palatine gan-glion blocks for the treatment of chronic muscle pain syndromes: a randomized, controlled trial. Pain 62(1):69–77, 1995.
  • See DM; Broumand N; Sahl L; Tilles JG. In vitro effect of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome. Immunophann-acology 35:229–235, 1997.
  • Self-reported illness and health status among Gulf War veterans. A population-based study. The Iowa Persian Gulf Study Group. Journal of the American Medical Asso-ciation 277(3):238–245, 1997.
  • Sendrowski DP; Buker EA; Gee SS. An investigation of sympathetic hypersensitivity in chronic fatigue syndrome. Optometry and Visual Sciences 74(8):660–663, 1997.
  • Sergi M; Rizzi M; Braghiroli A; Puttini PS; Greco M; Cazzola M; Andreoli A. Periodic breathing during sleep in patients affected by fibromyalgia syndrome. European Respiratory Journal 14(1):203–208, 1999.
  • Shanklin DR; Stevens MV; Hall NfF; Smalley DL. Environmental immunogens and T-cell-mediated responses in fibromyalgia: evidence for immune dysregulation and determinants of granuloma formation. Experimental Molecular Pathology 69(2): 102–118, 2000.
  • Shapiro CM. Fatigue: how many types and how common? Journal of Psychosomatic Research 45:1–3, 1998.
  • Sharpe M; Chalder T; Palmer I; Wessely S. Chronic fatigue syndrome: a practical guide to assessment and management. General Hospital Psychiatry 19(3):185–199, 1997.
  • Shaver IL; Lentz M; Landis CA; Heitkemper MNI; Buchwald DS; Woods NF. Sleep, psychological distress, and stress arousal in women with fibromyalgia. Research in Nursing and Health 20(3):247–257, 1997.
  • Shelkovnikov IA; Krivoruchko BI. [Pathogenesis of fibromyalgia] Patogenez fibromialgii. Patol Fiziol Eksp Ter (1):41–42, 1997.
  • Sherman JJ; Turk DC; Okifuji A. Prevalence and impact of posttraumatic stress disor-der-like symptoms on patients with fibromyalgia syndrome. Clinical Journal of Pain 16(2):127–134, 2000.
  • Sherry DD. Musculoskeletal pain in children. Current Opinions in Rheumatology 9(5):465–470, 1997.
  • Shojania K. Rheumatology: 2. What laboratory tests are needed? Canadian Medical Association Journal 162(8):1157–1163, 2000.
  • Sibbald B. Chronic fatigue syndrome comes out of the closet. Canadian Medical Asso-ciation Journal 159(5):537–541, 1998.
  • Sieb JP; Dorfler P; Tolksdorf K; Jakschik J. Endplate ultrastructure in a case of primary fibromyalgia. Clinical Rheumatology 16(6):637–638, 1997.
  • Siegel DM; Janeway D; Baum J. Fibromyalgia syndrome in children and adolescents: clinical features at presentation and status at follow-up. Pediatrics 101(3 Pt 1): 377–382, 1998.
  • Siegmeth W. [Panalgesia and the fibromyalgia concept] Panalgesie und das Fibro-myalgiekonzept. Wien Medizin Wochenschrtft 149(19-20):558–560, 1999.
  • Sigal LH. Diagnosis of Lyme disease. Journal of the American Medical Association 274(18):1427–1428, 1995.
  • Sigal LH; Chang DJ; Sloan V. 18 tender points and the "18-wheeler" sign: clues to the diagnosis of fibromyalgia. Journal of the American Medical Association 279(6): 434, 1998.
  • Silverman S; Gluck 0; Silver D; Tesser J; Wallace D; Neumann K; Metzger A; Morris R. The prevalence of autoantibodies in symptomatic and asymptomatic patients with breast implants and patients with fibromyalgia. Current Topics in Microbiol-ogy and Immunology 210:277-282, 1996.
  • Sim J; Adams N. Physical and other non-pharmacological interventions for fibro-myalgia. Baillieres Best Practice Research in Clinical Rheumatology 13(3):507–523, 1999.
  • Simms RW. Fibromyalgia syndrome: current concepts in pathophysiology, clinical features, and management. Arthritis Care Research 9(4):315–328, 1996.
  • Simms RW. Is there muscle pathology in fibromyalgia syndrome? Rheumatic Dis-eases Clinics of North America 22(2):245–266, 1996.
  • Simms RW. Fibromyalgia is not a muscle disorder. American Journal of Medical Sci-ences 315(6):346–350, 1998.
  • Simonson N. [Can tamoxifen relieve fibromyalgia?[ Kan tamoxifen lindra fibromyalgi? Lakartidningen 93(5):340, 1996.
  • Simpson M; Bennett A; Holland P. Chronic fatigue syndrome/myalgic encephal-omyelitis as a twentieth-century disease: analytic challenges. Journal of Analytical Psychology 42(2):191–199, 1997.
  • Sinsawaiwong S; Phanthumchinda K. Pentazocine-induced fibrous myopathy and lo-calized neuropathy. Journal of the Medical Association of Thailand 81(9):717–721, 1998.
  • Sivri A; Cindas A; Dincer F; Sivri B. Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients. Clinical Rheumatology 15(3):283–286, 1996.
  • Slavkin HC. Chronic disabling diseases and disorders: the challenges of fibromyalgia. Journal of the American Dental Association 128(11):1583–1589, 1997.
  • Singh BB; Berman BM; Hadhazy VA; Creamer P. A pilot study of cognitive behav-ioral therapy in fibromyalgia. Alternative Therapy Health Medicine 4(2):67–70, 1998.
  • Skeith KJ; Hussain MS; Coutts RT; Ramos-Remus C; Avina-Zubieta JA; Russell AS. Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia. Clinical Rheumatology 16(3):291–295, 1997.
  • Slotkoff AT; Radulovic DA; Clauw DJ. The relationship between fibromyalgia and the multiple chemical sensitivity syndrome. Scandinavian Journal of Rheumatology 26(5):364–367, 1997.
  • Smart PA; Waylonis GW; Hackshaw KY. Immunologic profile of patients with fibromyalgia. American Journal of Physical Medicine and Rehabilitation 76(3): 231–234, 1997.
  • Smith AJ. The analgesic effects of selective serotonin reuptake inhibitors. Journal of Psychopharmacology 12(4):407–413, 1998.
  • Smith MD. Fibromyalgia and disability. Journal of Rheumatology 24(1):229; discus-sion 230–231, 1997.
  • Smith MD. The fibromyalgia problem. Journal of Rheumatology 25(5):1027; discus-sion 1028–1030, 1998.
  • Smith MD. Relationship of fibromyalgia to site and type of trauma: comment on the ar-ticles by Buskila et al. and Aaron et al. Arthritis and Rheumatism 41(2):378–379, 1998.
  • Smith TC; Gray GC; Knoke JD. Is systemic lupus erythematosus, amyotrophic lateral sclerosis, or fibromyalgia associated with Persian Gulf War service? An examina-tion of Department of Defense hospitalization data. American Journal of Epidemi-ology 151(11):1053–1059, 2000.
  • Smith WA. Fibromyalgia syndrome. Nursing Clinics of North America 33(4):653–669, 1998.
  • Smythe HA; Moldofsky H. Two contributions to understanding "fibrositis" syndrome. Bulletin of Rheumatic Diseases 28:928–931, 1977.
  • Smythe HA. Studies of sleep in fibromyalgia; techniques, clinical significance, and fu-ture directions. British Journal of Rheumatology 34(10):897–899, 1995.
  • Smythe HA; Gladman A; Mader R; Peloso P; Abu-Shakra M. Strategies for assessing pain and pain exaggeration: controlled studies. Journal of Rheumatology 24(8): 1622–1629, 1997.
  • Smythe H. Examination for tenderness: learning to use 4 kg force. Journal of Rheum-otology 25(1):149–151, 1998.
  • Soderberg S; Lundman B; Norberg A. Living with fibromyalgia: sense of coherence, perception of well-being, and stress in daily life. Research on Nursing and Health 20(6):495–503, 1997.
  • Soderberg S; Lundman B; Norberg A. Struggling for dignity: the meaning of women's experiences of living with fibromyalgia. Quality Health Research 9(5):575–587, 1999.
  • Solomon DH; Liang MH. Fibromyalgia: scourge of humankind or bane of a rheum-atologist' s existence? Arthritis and Rheumatism 40(9):1553–1555, 1997.
  • Sorensen J; Bengtsson A; Ahlner J; Henriksson KG; Ekselius L; Bengtsson M. Fibromyalgia-are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. Journal of Rheumatology 24(8): 1615–1621, 1997.
  • Sorensen J; Graven-Nielsen T; Henriksson KG; Bengtsson M; Arendt-Nielsen L. Hyperexcitability in fibromyalgia. Journal of Rheumatology 25(1):152–155, 1998.
  • Sperber AD; Carmel S; Atzmon Y; Weisberg I; Shalit Y; Neumann L; Fich A; Buskila D. The sense of coherence index and the irritable bowel syndrome. A cross-sectional comparison among irritable bowel syndrome patients with and without coexisting fibromyalgia, irritable bowel syndrome non-patients, and controls. Scandinavian Journal of Gastroenterology 34(3):259–263, 1999a.
  • Sperber AD; Atzmon Y; Neumann L; Weisberg I; Shalit Y; Abu-Shakrah M; Fich A; Buskila D. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. American Journal of Gastroenterology 94(12):3541–3546, 1999b.
  • Sperber AD; Carmel S; Atzmon Y; Weisberg I; Shalit Y; Neumann L; Fich A; Friger M; Buskila D. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. American Journal of Gastroenterology 95(4):995–998, 2000.
  • Sprott H; Muller A; Heine H. Collagen crosslinks in fibromyalgia. Arthritis and Rheu-matism 40(8):1450–1454, 1997.
  • Sprott H; Muller A; Heine H. Collagen cross-links in fibromyalgia syndrome. Zeit-schrift Rheumatologie 57 Suppl 2:52–55, 1998.
  • Sprott H; Muller A. Collagen crosslinks as markers of a therapy effect in fibromyalgia. Clinical Experimental Rheumatology 16(5):626–627, 1998.
  • Sprott H; Franke S; Kluge H; HeM G. Pain treatment of fibromyalgia by acupuncture. Rheumatology International 18(1):35–36, 1998.
  • Sprott H; Bradley LA; Oh SJ; Wintersberger W; Alarcon GS; Mussell HG; Tseng A; Gay RE; Gay S. Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue. Arthritis and Rheumatism 41(9):1689–1694, 1998.
  • Sprott H; Rzanny R; Reichenbach JR; Kaiser WA; HeM G; Stein G. 31P magnetic res-onance spectroscopy in fibromyalgic muscle. Rheumatology (Oxford) 39(10): 1121–1125, 2000.
  • Sprott H; Jeschonneck M; Grohmann G; HeM G. [Microcirculatory changes over the tender points in fibromyalgia patients after acupuncture therapy (measured with la-ser-Doppler flowmetry)] Anderung der Durchblutung uber den tender points bei Fibromyalgie-Patienten nach einer Akupunkturtherapie (gemessen mit der La-ser-Doppler-Flowmetrie). Wien Klinische Wochenschrtft 112(13):580–586, 2000.
  • Staedt J; Windt H; Hajaki G; Soppe G; Rudolph G; Ensink FBM; et al. Cluster arousal analysis in chronic pain-disturbed sleep. Journal of Sleep Research 2:134–137, 1993.
  • Stanton T. Coping with stress on the job. Nursing in New Zealand 4(11):17–18, 1999. Stohler CS. Muscle-related temporomandibular disorders. Journal of Orofacial Pain 13(4):273–284, 1999.
  • Stoll AL. Fibromyalgia symptoms relieved by flupirtine: an open-label case series. Psychosomatics 41(4):371–372, 2000.
  • Stone RG; Wharton RB. Simultaneous multiple-modality therapy for tension head-aches and neck pain. Biomedical Instrumentation Technology 31(3):259–262, 1997. Stormorken H; Brosstad F. [The "diffuse" health problems of women] Kvinners "ubestemte" helseplager. Tidsskr Nor Laegeforen 119(20):3043, 1999.
  • Stratz T; Muller W. The use of 5-HT3 receptor antagonists in various rheumatic dis-eases-a clue to the mechanism of action of these agents in fibromyalgia? Scandina-vian Journal of Rheumatology Suppl 113:66–71, 2000a.
  • Stratz T; Muller W. Do predictors exist for the therapeutic effect of 5-HT3 receptor an-tagonists in fibromyalgia? Scandinavian Journal of Rheumatology Suppl 113: 63–65, 2000b.
  • Straub TA. Endoscopic carpal tunnel release: a prospective analysis of factors associ-ated with unsatisfactory results. Arthroscopy 15(3):269–274, 1999.
  • Straus SE; Tosato G; Armstrong G; et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Annals of Internal Medicine 102:7–16, 1985.
  • Streeten DH. The nature of chronic fatigue. Journal of the American Medical Associa-tion 1998; 280(12):1094–1095, 1998.
  • Strobel ES; Krapf M; Suckfull M; Bruckle W; Fleckenstein W; Muller W. Tissue oxy-gen measurement and 31P magnetic resonance spectroscopy in patients with mus-cle tension and fibromyalgia. Rheumatology International 16(5):175–180, 1997.
  • Strobel ES; Wild J; Muller W. [Interdisciplinary group therapy for fibromyalgia] Interdisziplinare Gruppentherapie fur die Fibromyalgie. Zeitschrtft Rheumatologie 57(2):89–94, 1998.
  • Strombeck B; Ekdahl C; Manthorpe R; Wikstrom I; Jacobsson L. Health-related qual-ity of life in primary Sjogren' s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scandinavian Journal of Rheum-atology 29(1):20–28, 2000.
  • Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Da-vis P. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians. Journal of Rheumatology 25(10): 1980–1985, 1998.
  • Suarez-Lozano I. Isolated general malaise of unknown origin: a new syndrome. Anales de Medicina Interna 14(4):209–210, 1997; Teran Diaz E: Anales de Medicina Interna 13(10):467–470, 1996.
  • Swezey RL; Adams J. Fibromyalgia: a risk factor for osteoporosis. Journal of Rheum-atology 26(12):2642–2644, 1999.
  • Tabeeva GR; Levin IaI; Korotkova SB; Khanunov IG. [Treatment of fibromyalgia]
  • Lechenie fibromialgii. Zh Nevrol Psikhiatr Im S S Korsakova 98(4):40–43, 1998. Tabeeva GR; Korotkova SB; Vein AM. [Fibromyalgia] Fibromialgiia. Zh Nevrol
  • Psikhiatr Im S S Korsakova 100(4):69–77, 2000.
  • Tan EM; Feltkamp TE; Smolen JS; Butcher B; Dawkins R; Fritzler MJ; Gordon T; Hardin JA; Kalden JR; Lahita RG; Maini RN; McDougal JS; Rothfield NF; Smeenk RJ; Takasaki Y; Wiik A; Wilson MR; Koziol JA. Range of antinuclear antibodies in "healthy" individuals. Arthritis and Rheumatism 40(9):1601–1611, 1997.
  • Tanum L; Malt UF. Sodium lactate infusion in fibromyalgia patients. Biological Psy-chiatry 38(8):559–561, 1995.
  • Tavoni A; Jeracitano G; Cirigliano G. Evaluation of S-adenosylmethionine in second-ary fibromyalgia: a double-blind study. Clinical and Experimental Rheumatology 16(1):106–107, 1998.
  • Tayag-Kier CE; Keenan GF; Scalzi LV; Schultz B; Elliott J; Zhao RH; Arens R. Sleep and periodic limb movement in sleep in juvenile fibromyalgia. Pediatrics 106(5): E70, 2000.
  • Taylor J; Skan J; Erb N; Carruthers D; Bowman S; Gordon C; Isenberg D. Lupus pa-tients with fatigue-is there a link with fibromyalgia syndrome? Rheumatology (Ox-ford) 39(6):620–623, 2000.
  • Taylor RM; Gabriel SE; O'Fallon WM; Bowles CA; Duffy J. A diagnostic algorithm for distinguishing the eosinophilia-myalgia syndrome from fibromyalgia and chronic myofascial pain. Journal of Rheumatology Suppl 46:13–18, 1996.
  • Teitelbaum JE; Bird B; Weiss A; Gould L. Low-dose hydrocortisone for chronic fa-tigue syndrome. Journal of the American Medical Association 281(20):1887–1888; discussion 1888–1889, 1999.ter Borg EJ; Gerards-Rociu E; Haanen HC; Westers P. High frequency of hysterecto-mies and appendectomies in fibromyalgia compared with rheumatoid arthritis: a pi-lot study. Clinical Rheumatology 18(1):1–3, 1999.
  • Thomas E; Ginies P; Blotman F. Fibromyalgia as a national issue: the French example. Baillieres Best Pract Research in Clinical Rheumatology 13(3):525–529, 1999.
  • Thomas WO 3rd; Harper LL; Wong SW; Michalski JP; Harris CN; Moore JT; Rodning CB. Explanation of silicone breast implants. American Surgery 63(5):421–429, 1997.
  • Thorson K. The fibromyalgia problem. Journal of Rheumatology 25(5):1023; discus-sion 1028–1030, 1998.
  • Thorson K. Is fibromyalgia a distinct clinical entity? The patient's evidence. Baillieres Best Practice Research in Clinical Rheumatology 13(3):463–467, 1999.
  • Thorsteinsdottir B; Rafnsdottir S; Geirsson AJ; Sigurjonsson SV; Kjeld M. No differ-ence in ubiquinone concentration of muscles and blood in fibromyalgia patients and healthy controls. Clinical and Experimental Rheumatology 16(4):513–514, 1998.
  • Tiesinga LJ; Dassen TW; Halfens RJ. Fatigue: a summary of the definitions, dimen-sions, and indicators. Nursing Diagnosis 7(2):51–62, 1996.
  • Tishler M; Barak Y; Paran D; Yaron M. Sleep disturbances, fibromyalgia and primary Sjogren's syndrome. Clinical and Experimental Rheumatology 15(1):71–74, 1997.
  • Toivanen P; Hansen DS; Mestre F; Lehtonen L; Vaahtovuo J; Vehma M; Mottonen T; Saario R; Luukkainen R; Nissila M. Somatic serogroups, capsular types, and spe-cies of fecal Klebsiella in patients with ankylosing spondylitis. Journal of Clinical Microbiology 37(9):2808–2812, 1999.
  • Torpy DJ; Chrousos GP. The three-way interactions between the hypothalamic-pitu-itary-adrenal and gonadal axes and the immune system. Baillieres Clinical Rheum-atology 10(2):181–198, 1996.
  • Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR. Re-sponses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis and Rheumatism 43(4):872–880, 2000.
  • Touchon J; Besset A; Billiard M; Simon L; Herrison C; Cadihac J. Fibrositis syn-drome: polysomnographic and psychological aspects. In: Koella WP; Obai F; Schulz H; Visser P, editors. Sleep '86. New York: Gustav Fischer Verlag: 1988, pp. 445–447.
  • Touchon J. [Use of antidepressants in sleep disorders: practical considerations] Utili-zation des antidepresseurs dans les troubles du sommeil : considerations pratiques. Encephale 21 Spec No 7:41–747, 1995.
  • Tougas G. The autonomic nervous system in functional bowel disorders. Canadian Journal of Gastroenterology 13 Suppl A:15A-17A, 1999.
  • Trojan DA; Cashman NR. Fibromyalgia is common in a postpoliomyelitis clinic. Ar-chives of Neurology 52(6):620–624, 1995.
  • Tuck I; Human N. The experience of living with chronic fatigue syndrome. Journal of Psychosocial Nursing & Mental Health Services 36(2):15–19, 1998.
  • Tuncer T; Butun B; Arman M; Akyokus A; Doseyen A. Primary fibromyalgia and al-lergy. Clinical Rheumatology 16(1):9–12, 1997.
  • Tunks E; McCain GA; Hart LE; Teasell RW; Goldsmith CH; Rollman GB; McDermid AJ; DeShane PJ. The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls. Journal of Rheumatology 22(5):944–52, 1995.
  • Turk DC; Okifuji A; Starz TW; Sinclair JD. Effects of type of symptom onset on psy-chological distress and disability in fibromyalgia syndrome patients. Pain 68(2-3): 423–430, 1996.
  • Turk DC; Okifuji A; Sinclair JD; Starz TW. Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. Journal of Rheumatology 23(7):1255–1262, 1996.
  • Turk DC; Okifuji A. Evaluating the role of physical, operant, cognitive, and affective factors in the pain behaviors of chronic pain patients. Behavior Modification 21(3):259–280, 1997.
  • Turk DC; Okifuji A; Sinclair JD; Starz TW. Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Ar-thritis Care Research 11(5):397–404, 1998.
  • Turk DC; Okifuji A; Sinclair JD; Starz TW. Interdisciplinary treatment for fibro-myalgia syndrome: clinical and statistical significance. Arthritis Care Research 11(3):186–195, 1998.
  • Unger J. Fibromyalgia. Journal of the American Academy of Nurse Practitioners 8(1):27–29, 1996.
  • Unraveling a mysterious cause of pain. Johns Hopkins Medical Letters on Health After 50 10(4):3, 1998.
  • Uppgaard RO. Definition of myofascial face pain. Journal of the American Dental As-sociation 131(7):854, 856, 858, 2000.
  • Vachtenheim J. [Non-steroidal antirheumatic ointments in the treatment of primary periarticular and intramuscular fibrositis] Nesteroidni antirevmatika v mast' ove forme v lecbe prvotni kolemkloubni a nitrosvalove fibrozitidy. Vnitr Lek 41(9): 609–612, 1995.
  • van der Meer JVV; Elving LD. Chronic fatigue- 'cured with 23 I's. Nederlands Tijdschrift voor Geneeskunde 141(31):1505–1507, 1997.
  • van der Meer JW; Rijken PM; Bleijenberg G; Thomas S; Hinloopen RJ; Bensing JM. Indications for management in long-term, physically unexplained fatigue symp-toms. Nederlands Tijdschrift voor Geneeskunde 141(31):1516–9, 1997.
  • Van Houdenhove B; Neerinckx E. Is "ergomania" a predisposing factor to chronic pain and fatigue? Psychosomatics 40(6):529–530, 1999.
  • Van Linthoudt D; Ferrari R; Babaiantz 0; Ott H. [Rheumatology expertise] Expertises rhumatologiques. Revue Medicale Suisse Romande 120(1):73–80, 2000.
  • Van Santen-Hoeufft M. Typical fibromyalgia. Clinical Rheumatology 15(3):233–235, 1996.
  • van Waveren EK. The rise and fall of the chronic fatigue syndrome as defined by Holmes et al. Medical Hypotheses 46(2):63–66, 1996.
  • Vasey FB; Aziz N. Breast implants and connective-tissue diseases. New England Jour-nal of Medicine 333 (21):1423 ; discussion 1424, 1995.
  • Vasey FB. Clinical experience with systemic illness in women with silicone breast im-plants: comment on the editorial by Rose. Arthritis and Rheumatism 40(8):1545, 1997.
  • Vestergaard-Poulsen P; Thomsen C; Norregaard J; Bulow P; Sinkjaer T; Henriksen O. 31P NMR spectroscopy and electromyography during exercise and recovery in pa-tients with fibromyalgia. Journal of Rheumatology 22(8):1544–1551, 1995.
  • Villanova M; Selvi E; Malandrini A; Casali C; Santorelli FM; De Stefano R; Marco-longo R. Mitochondrial myopathy mimicking fibromyalgia syndrome. Muscle Nerve 22(2):289–291, 1999.
  • Vlaeyen JVV; Teeken-Gruben NJ; Goossens ME; Rutten-van Molken MP; Pelt RA; van Eek H; Heuts PH. Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. I. Clinical effects. Journal of Rheumatology 23(7):1237–1245, 1996.
  • Volkmann H; Norregaard J; Jacobsen S; Danneskiold-Samsoe B; Knoke G; Nehrdich D. Double-blind, placebo-controlled cross-over study of intravenous S-adenosyl-
  • L-methionine in patients with fibromyalgia. Scandinavian Journal of Rheuma-tology 26(3):206–211, 1997.
  • Vree R. Fireworks over fibromyalgia, CFS, and IBS. Postgraduate Medicine 102(6): 44, 1997.
  • Wachter KC; Kaeser HE; Guhring H; Ettlin TM; Mennet P; Muller W. Muscle damp-ing measured with a modified pendulum test in patients with fibromyalgia, lum-bago, and cervical syndrome. Spine 21(18):2137–2142, 1996.
  • Wacker HR. [Epidemiology and comorbidity of depressive disorders] Epidemiologie und Komorbiditat von Depressionen. Ther Umsch 57(2):53–58, 2000.
  • Wadsworth F; Kennedy S; Bradlow A; Barlow D; David J. Gynecological symptoms in fibromyalgia. British Journal of Rheumatology 34(9):888–889, 1995.
  • Wagener P; HeM R; Felstehausen KH. [Gynecologic operations in fibromyalgia syn-drome. A retrospective analysis of 890 patients of a rheumatologic and general practice] Gynakologische Operationen beim Fibromyalgiesyndrom. Eine retro-spektive Analyse an 890 Patientinnen einer rheumatologischen und einer All-gemeinpraxis. Fortschrift Medizin 115(24):39–40, 1997.
  • Walker EA; Keegan D; Gardner G; Sullivan M; Katon WJ; Bernstein D. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagno-ses and functional disability. Psychosomatic Medicine 59(6):565–571, 1997.
  • Walker EA; Keegan D; Gardner G; Sullivan M; Bernstein D; Katon WJ. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosomatic Medicine 59(6):572–577, 1997.
  • Walker EA; Katon WJ; Keegan D; Gardner G; Sullivan M. Predictors of physician frustration in the care of patients with rheumatological complaints. General Hospi-tal Psychiatry 19(5):315–323, 1997.
  • Wallace DJ: Prevalence of fibromyalgia in systemic lupus erythematosus patients: comment on the article by Middleton et al. Arthritis and Rheumatism 38(6):872, 1995.
  • Wallace DJ. The fibromyalgia syndrome. Annals of Medicine 29(1):9–21, 1997. Wallace DJ; Shapiro S; Panush RS. Update on fibromyalgia syndrome. Bulletin of Rheumatic Diseases 48(5):1–4, 1999.
  • Wallace DJ. What constitutes a fibromyalgia expert? Arthritis Care Research 12(2): 82–84, 1999.
  • Walsh JK; Hartman PG; Schweitzer PK. Slow wave sleep deprivation and waking function. Journal of Sleep Research 3:16–25, 1994.
  • Walter B; Vaitl D; Frank R. Affective distress in fibromyalgia syndrome is associated with pain severity. Zeitschrtft Rheumatologie 57 Suppl 2:101–104, 1998. Wang B; Gladman DD; Urowitz MB. Fatigue in lupus is not correlated with disease ac-tivity. Journal of Rheumatology 25(5):892–895, 1998.
  • Ward MH; DeLisle H; Shores JH; Slocum PC; Foresman BH. Chronic fatigue com-plaints in primary care: incidence and diagnostic patterns. Journal of the American Osteopathic Association 96(1):34–46, 41, 1996.
  • Ware JC; Russell IJ; Campos E. Alpha intrusions into the sleep of depression and fibromyalgia syndrome (fibrositis) patients. Sleep Research 15:210, 1986.
  • Warner E; Keshavjee al-N; Shupak R; Bellini A. Rheumatic symptoms following adjuvant therapy for breast cancer. American Journal of Clinical Oncology 20(3): 322–326, 1997.
  • Webb SM. Fibromyalgia and melatonin: are they related? Clinical Endocrinology (Oxf) 49(2):161–162, 1998.
  • Weber U. [Fibromyalgia (generalized tendomyopathy) expert assessment practice] Die Fibromyalgie (Generalisierte Tendomyopathie) in der Begutachtungs situation. Schweize Rundschrift Medizin Prax 87(24):856, 1998.
  • Weibel RE; Benor DE. Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the National Vaccine In-jury Compensation Program. Arthritis and Rheumatism 39(9):1529–1534, 1996.
  • Weigent DA; Bradley LA; Blalock JE; Alarcon GS. Current concepts in the patho-physiology of abnormal pain perception in fibromyalgia. American Journal of Med-ical Sciences 315(6):405–412, 1998.
  • Weiss B. Neurobehavioral properties of chemical sensitivity syndromes. Neurotoxi-cology 19(2):259–268, 1998.
  • Weiss DJ; Kreck T; Albert RK. Dyspnea resulting from fibromyalgia. Chest 113(1): 246–249, 1998.
  • Wessely S. Chronic fatigue syndrome. Summary of a report of a joint committee of the Royal College of Physicians, Psychiatrists and General Practitioners. Journal of the Royal College of Physicians of London 30(6):497–504, 1996.
  • Wessely S. The epidemiology of chronic fatigue syndrome. Epidemiologia E Psichiatria Sociale 7(1):10–24, 1998.
  • Wessely S. Chronic fatigue syndrome: a 20th century illness? Scandinavian Journal of Work, Environment & Health 23 (Suppl 3):17–34, 1997.
  • Wessely S; Hotopf M. Is fibromyalgia a distinct clinical entity? Historical and epide-miological evidence. Baillieres Best Practice Research in Clinical Rheumatology 13(3):427–436, 1999.
  • White A. The fibromyalgia syndrome. Electroacupuncture is a potentially valuable treatment. British Medical Journal 310(6991):1406, 1995.
  • White KP; Harth M; Teasell RW. Work disability evaluation and the fibromyalgia syn-drome. Seminars in Arthritis and Rheumatism 24(6):371–381, 1995.
  • White KP; Harth M. An analytical review of 24 controlled clinical trials for fibro-myalgia syndrome (FMS). Pain 64(2):211–219, 1996.
  • White KP; Harth M. The fibromyalgia problem. Journal of Rheumatology 25(5): 1022–1023; discussion 1028–1030, 1998.
  • White KP; Speechley M; Harth M; O stbye T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random com-munity cases of fibromyalgia versus controls. Journal of Rheumatology 26(7): 1577–1585, 1999a.
  • White KP; Harth M; Speechley M; Ostbye T. Testing an instrument to screen for fibromyalgia syndrome in general population studies: the London Fibromyalgia Epidemiology Study Screening Questionnaire. Journal of Rheumatology 26(4): 880–884, 1999b.
  • White KP; Speechley M; Harth M; O stbye T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. Journal of Rheumatology 26(7):1570–1576, 1999c.
  • White KP; Speechley M; Harth M; O stbye T. The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada. Jour-nal of Rheumatology 26(4):885–889, 1999d.
  • White KP; Harth M. The occurrence and impact of generalized pain. Baillieres Best Practice Research in Clinical Rheumatology 13(3):379–389, 1999.
  • White KP; Speechley M; Harth M; Ostbye T. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis and Rheumatism 42(1):76–83, 1999.
  • White KP; Speechley M; Harth M; Ostbye T. Co-existence of chronic fatigue syn-drome with fibromyalgia syndrome in the general population. A controlled study. Scandinavian Journal of Rheumatology 29(1):44–51, 2000.
  • White KP; Carette S; Harth M; Teasell RW. Trauma and fibromyalgia: is there an asso-ciation and what does it mean? Seminars in Arthritis and Rheumatism 29(4): 200–216, 2000a.
  • White KP; Ostbye T; Harth M; Nielson W; Speechley M; Teasell R; Bourne R. Per-spectives on posttraumatic fibromyalgia: a random survey of Canadian general practitioners, orthopedists, physiatrists, and rheumatologists. Journal of Rheuma-tology 27(3):790–796, 2000b.
  • White PD. The relationship between infection and fatigue. Journal of Psychosomatic Research 43(4):345–350, 1997.
  • Whiteside TL; Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. American Journal of Medicine 1998; 105(3A):27S-34S, 1998.
  • Wigers SH. Fibromyalgia outcome: the predictive values of symptom duration, physi-cal activity, disability pension, and critical life events-a 4.5 year prospective study. Journal of Psychosomatic Research 41(3):235–243, 1996.
  • Wigers SH; Stiles TC; Vogel PA. Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology 25(2):77–86, 1996.
  • Wigley RD. Can accident or occupation cause fibromyalgia. New Zealand Medical Journal 27;111(1060):60, 1998.
  • Wigley R. Can fibromyalgia be separated from regional pain syndrome affecting the arm? Journal of Rheumatology 26(3):515–516, 1999.
  • Wik G; Fischer H; Bragee B; Finer B; Fredrikson M. Functional anatomy of hypnotic analgesia: a PET study of patients with fibromyalgia. European Journal of Pain 3(1):7–12, 1999.
  • Wikner J; Hirsch U; Wetterberg L; Rojdmark S. Fibromyalgia-a syndrome associated with decreased nocturnal melatonin secretion. Clinical Endocrinology (Oxf) 49(2): 179–183, 1998.
  • Wilke WS. Fibromyalgia: more than a label. Cleveland Clinic Journal of Medicine 63(2):87–89, 1996.
  • Wilke WS. Fibromyalgia. Recognizing and addressing the multiple interrelated fac-tors. Postgraduate Medicine 100(1):153–156, 159, 163–166 passim, 1996.
  • Wilke WS; Fouad-Tarazi FM; Cash JM; Calabrese LH. The connection between chronic fatigue syndrome and neurally mediated hypotension. Cleveland Clinic Journal of Medicine 65(5):261–266, 1998.
  • Wilson RB; Gluck OS; Tesser JR; Rice JC; Meyer A; Bridges AJ. Antipolymer anti-body reactivity in a subset of patients with fibromyalgia correlates with severity. Journal of Rheumatology 26(2):402–407, 1999.
  • Winfield JB. Fibromyalgia: what's next? Arthritis Care Research 10(4):219–221, 1997.
  • Winfield JB. Pain in fibromyalgia. Rheumatic Diseases Clinics of North America 25(1):55–79, 1999.
  • Winfield JB. Psychological determinants of fibromyalgia and related syndromes. Cur-rent Reviews on Pain 4(4):276–286, 2000.
  • Wittig RM; Zorick FJ; Blumer D; Heilbronn M; Roth T. Disturbed sleep in patients complaining of chronic pain. Journal of Nerve and Mental Diseases 170:429–431, 1982.
  • Wittrup IH; Christensen LS; Jensen B; Danneskiold-Samsoe B; Bliddal H; Wiik A. Search for Boma disease virus in Danish fibromyalgia patients. Scandinavian Jour-nal of Rheumatology 29:387–390, 2000.
  • Wolf H. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists. Scandinavian Journal of Rheumatology Suppl 113:37–45, 2000.
  • Wolfe F; Cathey MA. Prevalence of primary and secondary fibrositis. Journal of Rheumatology 10:965–968, 1983.
  • Wolfe F; Smythe HA; Yunus MB; Bennett RM; Bombardier C; Goldenberg DL; et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis and Rheuma-tism 33:160–172, 1990.
  • Wolfe F. The epidemiology of drug treatment failure in rheumatoid arthritis. Baillieres Clinical Rheumatology 9(4):619–632, 1995.
  • Wolfe F. The fibromyalgia syndrome: a consensus report on fibromyalgia and disabil-ity. Journal of Rheumatology 23(3):534–539, 1996.
  • Wolfe F; Hawley DJ; Wilson K. The prevalence and meaning of fatigue in rheumatic disease. Journal of Rheumatology 23(8):1407–1417, 1996.
  • Wolfe F; Potter J. Fibromyalgia and work disability: is fibromyalgia a disabling disor-der? Rheumatic Disease Clinics of North America 22(2):369–391, 1996.
  • Wolfe F; Anderson J; Harkness D; Bennett RM; Caro XJ; Goldenberg DL; Russell LT; Yunus MB. Health status and disease severity in fibromyalgia: results of a six-cen-ter longitudinal study. Arthritis and Rheumatism 40(9):1571–1579, 1997.
  • Wolfe F; Anderson J; Harkness D; Bennett RM; Caro XJ; Goldenberg DL; Russell LT; Yunus MB. Work and disability status of persons with fibromyalgia. Journal of Rheumatology 24(6):1171–1178, 1997.
  • Wolfe F. The fibromyalgia problem. Journal of Rheumatology 24(7):1247–1249, 1997.
  • Wolfe F; Anderson J; Harkness D; Bennett RM; Caro XJ; Goldenberg DL; Russell LT; Yunus MB. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis and Rheumatism 40(9):1560–1570, 1997.
  • Wolfe F; Hawley DJ. Measurement of the quality of life in rheumatic disorders using the EuroQol. British Journal of Rheumatology 36(7):786–793, 1997.
  • Wolfe F; Russell LT; Vipraio G; Ross K; Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. Journal of Rheumatology 24(3):555–559, 1997.
  • Wolfe F. The relation between tender points and fibromyalgia symptom variables: evi-dence that fibromyalgia is not a discrete disorder in the clinic. Annals of Rheumatic Diseases 56(4):268–271, 1997.
  • Wolfe F. What use are fibromyalgia control points? Journal of Rheumatology 25(3): 546–550, 1998.
  • Wolfe F; Hawley DJ. Psychosocial factors and the fibromyalgia syndrome. Zeitschrift Rheumatologie 57 Suppl 2:88–91, 1998.
  • Wolfe F. Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology (Oxford) 38(4):355–361, 1999.
  • Wolfe F; Hawley DJ. Evidence of disordered symptom appraisal in fibromyalgia: in-creased rates of reported comorbidity and comorbidity severity. Clinical and Ex-perimental Rheumatology 17(3):297–303, 1999.
  • Wolfe F; Kong SX. Rasch analysis of the Western Ontario MacMaster questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibro-myalgia. Annals of Rheumatic Diseases 58(9):563–568, 1999.
  • Wolfe F; Anderson J. Silicone filled breast implants and the risk of fibromyalgia and rheumatoid arthritis. Journal of Rheumatology 26(9):2025–2028, 1999.
  • Wolfe F. "Silicone related symptoms" are common in patients with fibromyalgia: noevidence for a new disease. Journal of Rheumatology 26(5):1172–1175, 1999. Wolfe F. For example is not evidence: fibromyalgia and the law. Journal of Rheuma-tology 27(5):1115–1116, 2000.
  • Wolfe F; Hawley DJ; Goldenberg DL; Russell IJ; Buskila D; Neumann L. The assess-ment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 func-tional scales and the development of the FM Health Assessment Questionnaire. Journal of Rheumatology 27(8):1989–1999, 2000.
  • Wolfe F; Skevington SM. Measuring the epidemiology of distress: the rheumatology distress index. Journal of Rheumatology 27(8):2000–2009, 2000.
  • Wolfe F; Zhao S; Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis and Rheumatism 43(2):378–385, 2000.
  • Wolfe F. Management of fibromyalgia. Annals of Internal Medicine 132(12):1004; discussion 1005, 2000.
  • Wootton JC. Fibromyalgia. Journal of Womens Health and Gender Based Medicine 9(5):571–573, 2000.
  • Worz R. [Fibromyalgia-a current challenge. Considerations for insurance and social security dimensions] Fibromyalgie-eine Herausforderung unserer Zeit. Beachtenswerte versicherungs- und sozialrechtliche Dimension. Fortschrift Medizin 117(5):37, 1999.
  • Wright EF; Des Rosier KF; Clark MK; Bifano SL. Identifying undiagnosed rheumatic disorders among patients with TMD. Journal of the American Dental Association 128(6):738–744, 1997.
  • Xie X; Ye C. [Clinical analysis of 120 patients with fibromyalgia]. Hunan I Ko Ta Hsueh Hsueh Pao 22(2):167–170, 1997.
  • Xie X; Yang Q; Zhang J; Tan Y; Li X; Liu Y. [Relation between fibromyalgia and bac-terial urine]. Hunan I Ko Ta Hsueh Hsueh Pao 23(2):217, 1998.
  • Yang J; Kuikka JT; Vanninen E; Kauppinen T; Lansimies E; Patomaki L. Evaluation of scatter correction using a single isotope for simultaneous emission and transmis-sion data. Phantom and clinical patient studies. Nuklearmedizin 38(2):49–55, 1999.
  • Yaron I; Buskila D; Shirazi I; Neumann L; Elkayam 0; Paran D; Yaron M. Elevated levels of hyaluronic acid in the sera of women with fibromyalgia. Journal of Rheumatology 24(11):2221–2224, 1997.
  • Yavuz S; Fresko I; Hamuryudan V; Yurdakul S; Yazici H. Fibromyalgia in Behcet's syndrome. Journal of Rheumatology 25(11):2219–2220, 1998.
  • Young VL; Nemecek JR; Schwartz BD; Phelan DL; Schorr MW. HLA typing in women with breast implants. Plastic and Reconstructive Surgery 96(7):1497–1519; discussion 1520, 1995.
  • Yunus MB; Masi AT; Calabro JJ; Miller KA; Feigenbaum SI. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched controls. Seminars in Arthri-tis and Rheumatism 11:151–172, 1981.
  • Yunus MB; Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syn-drome: a controlled study. British Medical Journal 312(7042):1339, 1996.
  • Yunus MB. Genetic factors in fibromyalgia syndrome. Zeitschrift Rheumatologie 57 Suppl 2:61–62, 1998.
  • Yunus MB; Khan MA; Rawlings KK; Green JR; Olson JM; Shah S. Genetic linkage analysis of multicase families with fibromyalgia syndrome. Journal of Rheuma-tology 26(2):408–412, 1999.
  • Yunus MB; Inanici F; Aldag JC; Mangold RF. Fibromyalgia in men: comparison of clinical features with women. Journal of Rheumatology 27(2):485–490, 2000.
  • Zborovskii AB; Babaeva AR. [New trends in the study of the primary fibromyalgic syndrome] Novye napravleniia v izuchenii sindroma pervichnoi fibromialgii. Vestn Ross Akad Med Nauk (11):52–56, 1996.
  • Zborovskii AB; Babaeva AR. [Diagnosis of primary fibromyalgia: clinical criteria] Klinicheskie kriterii diagnoza pervichnoi fibromialgii. Klin Med (Mosk) 76(8): 18–21, 1998.
  • Zetterberg C. [Unclear pathomechanism behind neck-shoulder pain. Problem with in-surance claim] Oklar patomekanism bakom nack-skuldervark. Problem vid for-sakringsmedicinsk bedomning. Lakartidningen 93(9):793–796, 1996.
  • Ziem G; Donnay A. Chronic fatigue, fibromyalgia, and chemical sensitivity: overlap-ping disorders. Archives of Internal Medicine 155(17):1913, 1995.
  • Ziem G; MeTamney J. Profile of patients with chemical injury and sensitivity. Envi-ronmental Health Perspectives 105 Suppl 2:417–436, 1997.
  • Zierhut M; Schlote T; Stubiger N; Daikeler T; Kotter I; Bless D; Koitschev A. [Cogan I syndrome: clinical aspects, therapy and prognosis] Cogan I-Syndrom: Klinik, Therapie und Prognose. Ophthalmologe 97(3):197–202, 2000.
  • Zucker DR; Schmid CH; McIntosh MW; D'Agostino RB; Selker HP; Lau J. Com-bining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. Journal of Clinical Epidemiol-ogy 50(4):401–410, 1997.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.